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On 23 November 2006, Noel Ahern TD, Minister of State 
with responsibility for the National Drugs Strategy, launched 
A community drugs study: developing community indicators 
for problem drug use.1 Dr Hilda Loughran and Dr Mary Ellen 
McCann of University College Dublin completed the study on 
behalf of the National Advisory Committee on Drugs (NACD). 
This report focused on three communities’ experiences 
of the changes in the drug situation and responses to it 
between 1996 and 2004. The three communities selected 
were Ballymun, Bray and Crumlin. Minister Ahern said ‘this 
report provides evidence of the impact and effectiveness of 
Government policy on drugs since 1996’. 
The objectives of the study as stated in the report (p. 8) were: 
To explore [communities’] experiences of drug issues from 
1996 to 2004
To describe initiatives developed between 1996 and  
2002 which the communities perceive to have  
influenced any change
To explore how the communities experienced their involvement in planning and implementation 
of such initiatives
To assess how the then community infrastructure affected the communities’ experiences.
A grounded theory approach was used to gather and analyse the data collected through focus 
groups, in-depth interviews, key participant interviews, transcriptions from team meetings, local 
documentation and reflections of the research co-ordinators. Local people were recruited and trained 
as community researchers, who then recruited the participants through their community network. A 
total of 97 participants were interviewed across the three sites. All data collected were transcribed, 
coded and analysed in order to construct individual community profiles for the period 1996 to 2004 
and identify themes across the three community profiles. Twelve themes emerged. 
The key findings of the study were:
Between 1996 and 2004, polydrug use (which includes alcohol) replaced heroin as the main 
drug problem for all of the communities involved in the study. The misuse of both prescribed and 
non-prescribed benzodiazepines was noted. The use of cannabis was seen as widespread and had 
become a ‘normal’ practice by the end of the study period. 
Alcohol misuse had a major negative effect on the lives of residents in the communities. The 
more problematic aspects of alcohol use were under-age drinking and subsequent anti-social 
behaviour among this age group. The easy availability of alcohol was due to an increase in local 
supermarkets and off-licences in the three communities during the study period.
There was an improvement in the provision of opiate treatment and community-based treatment 
interventions between 1996 and 2004. Methadone substitution programmes had some impact 
on heroin use but failed to tackle other drugs. Concerns were raised regarding the lack of 
treatment facilities for young people, in particular for alcohol. 
Drug-related deaths and deaths among drug users caused devastation in the three communities. 
In general, these were premature deaths of young people. There was a general perception that 
official statistics did not reflect the total numbers who died or the impact of these deaths on 
other family members and the community at large. 
n
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A general sense of fear, vulnerability and 
intimidation was experienced among the 
communities as a result of open drug 
dealing in public areas. People reported 
that there had been a decrease in the use of 
public spaces after dark since 1996. 
A reduction in some types of crime was 
observed between 1996 and 2004, but the 
later phase of the study noted an increase in 
the number of murders associated with drug 
dealing. 
Participants reported a deteriorating 
relationship between the community and 
the gardaí.
There was an increase in the number 
of children under 15 years who stayed 
in school and an increase in those who 
completed the Leaving Certificate during 
the reporting period. In some cases, school 
absenteeism replaced early school leaving.
n
n
n
n
Employment opportunities had increased 
during the reporting period, and fewer 
people were unemployed in 2004.
The report states ‘It was evident from the data 
that there were different perceptions among 
community members as to the prevalence of 
drug use in their areas, and the consequences 
of different patterns of drug use’ (p. 77). This is 
due to the diversity of the communities and the 
difficulty in gathering data. The report’s main 
conclusion is that a community-based reporting 
system is required to identify changes in the 
drug situation in specific communities.  
(Siobhán Reynolds)
1.  Loughran H and McCann ME (2006) A 
community drugs study: developing community 
indicators for problem drug use. Dublin: 
Stationery Office.
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The report of a working group convened by the 
Irish College of General Practitioners (ICGP) to 
examine the issue of drug-related deaths and 
strategies for prevention was published on 21 
December 2006.1 The ICGP Working Group 
believes that, with suitable education and 
improved awareness of the issues involved in 
drug-related deaths, lives can be saved. The group 
supports the provisions for senior ambulance 
personnel with special training to carry naloxone 
as an emergency response to opiate overdose.
Recommendations made in the report include: 
A national co-ordinated strategy to prevent 
opiate-related deaths should be implemented.
Links should be established between the 
National Suicide Prevention Strategy, the 
National Parasuicide Registry and the National 
Drug-Related Deaths Index, in view of the 
overlap between substance abuse and suicide.
Appropriate information and resource 
materials should be standardised across all 
treatment and support locations.
All personnel who treat drug users should 
receive training in overdose prevention and 
basic life-support. Family members of known 
drug users should also consider receiving basic 
life-support training.
Individuals at high risk of overdose can be 
identified and service providers should address 
risky behaviours with these service users.
n
n
n
n
n
Consideration should be given to the provision 
of overdose prevention education groups for 
service users.
On discharge from prison, drug users should 
be allowed to link in with their local drug 
treatment agency, with contact numbers 
contained in a ‘pre-release’ pack.
Prison service personnel should facilitate 
contact with local HSE services wherever 
possible when a known drug user is being 
discharged.
Drug users undergoing detoxification should 
be told of the risks of overdose following 
detoxification.
Garda members should receive training in 
overdose prevention.
The National Drugs Strategy Team should 
research the feasibility of collecting data on 
non-fatal opiate overdoses or near misses.
The ICGP Working Group was chaired by Dr Ide 
Delargy, director of the Drug Misuse Programme 
of the ICGP and included representatives from  
the HSE, the voluntary sector, the Health  
Research Board and the Irish Prison Service.  
(Ena Lynn)
1.   ICGP Working Group (2006) Drug-related 
deaths and strategies for prevention. Dublin: 
ICGP. The full report is available on the ICGP 
website at www.icgp.ie
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In March 2004 CityWide published the results of a 
survey on the extent to which 27 community-based 
drug projects were dealing with the problems of 
cocaine use.1 The results illustrated that cocaine 
was a growing problem.
CityWide conducted a follow-up survey on cocaine 
in local communities in 2006.2 Twenty-eight 
projects responded to this survey, 13 of which 
had participated in the 2004 survey. The results 
show that local community drug projects have 
experienced a major increase since 2004 in people 
presenting with cocaine as their primary drug.
In 2004, four projects (15%) reported seeing clients 
with what they then described as problematic 
cocaine use. Two years later, 62% of projects 
reported treating clients presenting with cocaine as 
their primary drug. Figure 1 shows that a majority 
of projects reported an increase in cocaine use 
among clients since 2004.
The follow-up survey reports a deterioration in the 
general health of clients with problematic cocaine 
use, with 39% of the projects surveyed reporting a 
rise in the number of clients experiencing abscesses 
and wounds due to poor injecting habits. Twenty-
two per cent of projects reported an increase in 
mental health problems, including depression, 
anxiety, stress, psychotic episodes and attempted 
suicide. 
Projects also reported increases in weight loss, 
sexually transmitted infections (STIs), heart 
conditions, amputations, opiate users stabilised on 
methadone destabilising with cocaine use, and risk 
taking among clients using cocaine. One project 
reported being aware of one heroin-related death 
in the 10 years up to 2005, in comparison with 
knowledge of four cocaine-related deaths in 2006.
All projects expressed concern about clients who got 
into financial debt, resulting in their living in fear of 
violent reprisal for debts unpaid, and engaging in 
increased criminal activity to feed their addiction. The 
majority of projects surveyed reported an increase in 
violent and gun-related crime since 2004.
The projects reported a strain on resources due to 
cocaine use. This was due to the chaotic lifestyle and 
behaviours that can be associated with cocaine use 
and the reported problem of opiate-using clients 
destabilising through cocaine use.
Since 2004, in response to the growing problem of 
cocaine use, three cocaine-specific pilot projects have 
been set up and 93% of the projects surveyed in 
2006 had key workers who had undertaken cocaine-
related training. (Ena Lynn) 
1.  Citywide (2004) Cocaine in local communities: 
Survey of community drug projects. Dublin: CityWide 
Drugs Crisis Campaign. www.citywide.ie
2.  CityWide (2006) Cocaine in local communities: 
CityWide follow-up survey. Dublin: CityWide Drugs 
Crisis Campaign. www.citywide.ie
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Figure 1   Number of projects reporting an increase in cocaine use among clients
Source: CityWide (2006)
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Barry Cullen, Head of the Addiction Research Centre at 
Trinity College Dublin, prepared a report to assist with the 
development of a treatment response to drug and alcohol 
use among adolescents (12–18 years) living in Carlow, 
Kilkenny, South Tipperary, Waterford and Wexford.1 The 
report presented a review of the literature which examined 
adolescent needs, substance misuse pathways and 
treatment outcomes. In addition, the author discussed with 
service providers the issues pertaining to prevention, early 
intervention and treatment for adolescents living in this area. 
Alcohol and cannabis were the main problem drugs 
reported by adolescents living in the HSE South Eastern 
Area; opiate use was reported by only a small number of 
these adolescents. (Opiates are the most common main 
problem drug reported by adolescents living in the HSE 
Eastern Area.) The author reported that the pattern of 
substance use needed to be reflected in the development 
of the treatment response.
According to the author, there are intrinsic differences 
in the ways children and adults use alcohol and drugs 
and in their treatment needs. He describes two pathways 
into alcohol and drug use for adolescents. The first is the 
experimental or social use of alcohol or drugs (considered 
normal), and the second is the use of such substances 
as a coping mechanism to deal with stress and anxiety 
(considered problematic). 
The recommendations of this report were influenced by 
the Report of the working group on the treatment of under 18 
year olds presenting to treatment services with serious drug 
problems.2 In general, the four-tier model of service delivery 
recommended by the national working group was accepted 
as the best model, but service providers recommended 
adaptations to reflect the situation in the HSE South Eastern 
Area. The adaptations to the model should reflect the types of 
substances used and a preference for the provision of day care 
instead of residential care at Tier 4. The model recommended 
in the working group report is described below.
Experimental substance use should be dealt with using a 
population-based approach (Tier 1), while substance use 
to deal with stress and anxiety should be dealt with using a 
treatment intervention (Tiers 2 to 4). In order to determine 
which pathway to substance use was taken by the 
adolescent, an appropriate assessment tool was required. A 
review of the evidence indicated that effective interventions 
for those requiring treatment were behavioural therapy, 
motivational counselling, multi-systemic treatment and 
family therapy. Family involvement in treatment was very 
important for younger or less mature adolescents, and 
less so for the more mature young person. A specialist 
day-care programme was recommended as an alternative 
to residential treatment, which, according to the author, 
should be used for respite purposes only. In order to ensure 
appropriate use of Tier 3 and Tier 4 services, referrals to 
these services should be made through Tier 2 services. The 
author recommended that adolescent services in the South 
East be delivered through a separate adolescent drug 
treatment service. The provision of community and youth 
projects in urban areas was considered adequate but there 
was a need to expand these to rural communities. During 
consultations with service providers, it was noted that 
many at Tier 1 were unaware of the availability of services 
required to manage those with problematic substance use, 
and in-service training was needed to ensure adequate 
knowledge and appropriate referral. (Jean Long)
1.   Cullen B (2006) Report to Health Service Executive 
Regional Drug Coordinating Office (Wateford) on 
recommendations for developing adolescent substance 
misuse treatment services in the region. Dublin: Addiction 
Research Centre, Trinity College Dublin. 
2.   Working Group on treatment of under 18 year olds 
(2005) Report of the working group on treatment of under 
18 year olds presenting to treatment services with serious 
drug problems. Dublin: Department of Health and 
Children.
Strategy to address adolescent substance 
misuse in the HSE South Eastern Area
Tier 1  Generic services provided by teachers, social services, gardaí, general practitioners, community and family groups 
for those at risk of drug use. Generic services would include advice and referral and would be suitable for those 
considering or commencing experimentation with drugs or alcohol. 
Tier 2  Services with specialist expertise in either adolescent mental health or addiction, such as juvenile liaison officers, 
local drugs task forces, home-school liaison, Youthreach, general practitioners specialising in addiction and 
drug treatment centres. The types of service delivered at this level would include drug-related prevention, brief 
intervention, counselling and harm reduction, and would be suitable for those encountering problems as a result 
of drug or alcohol use. 
Tier 3  Services with specialist expertise in both adolescent mental health and addiction. These services would have 
the capacity to deliver child-centred comprehensive treatments through a multi-disciplinary team. This team 
would provide medical treatment for addiction, psychiatric treatment, child protection, outreach, psychological 
assessment and interventions, and family therapy. These types of service would be suitable for those encountering 
substantial problems as a result of drug or alcohol use. 
Tier 4  Services with specialist expertise in both adolescent mental health or addiction and the capacity to deliver a brief, 
but very intensive intervention through an inpatient or day hospital. These types of service would be suitable for 
those encountering severe problems as a result of drugs or alcohol dependence.
In the last issue of Drugnet Ireland the findings of the 
report Smoking, Alcohol and Drug Use in Cork and Kerry 
20041 in respect of alcohol consumption and drug use 
were described.2 Comparisons with the findings of an 
earlier study by the same author, Dr Timothy Jackson, 
in 1996, and with the results of other recent studies of 
substance use in Ireland, were also described. 
In this article the findings of the report in respect of 
community awareness of illicit drugs and perceptions 
of drug-related issues are described, along with 
comparisons with the 1996 findings.3 Mirroring the 
trend shown by the research that drug and alcohol use 
in the region had increased since 1996, the study also 
found that awareness of illicit drugs and drug use in 
the region had increased over the past eight years and 
that attitudes and opinions on substance misuse issues 
had shifted. 
Drugs
Awareness of almost all drugs had increased since 
1996. Significant increases were also found in 
the proportion of respondents claiming personal 
knowledge of drug situations, including knowing 
someone who had been offered drugs, had taken 
drugs in the last five years or regularly took drugs, or 
being in social gatherings in the last five years where 
drugs were taken by others. Since 1996 the proportion 
of respondents with such knowledge had increased for 
cannabis, cocaine, crack and heroin, while dropping 
for ecstasy, magic mushrooms and LSD. As in 1996, 
the main source of awareness among all respondents of 
people using drugs in their area was personal contacts. 
Responses to a question about the harmfulness of 
individual drugs showed that, as in 1996, heroin, 
ecstasy, crack, cocaine and LSD were considered 
the most harmful, and cannabis the least harmful. 
Medically prescribed drugs fell midway in the ranking. 
The author reports that cannabis use was twice as 
frequent among those who thought the substance 
least harmful as among those who saw it as harmful. 
This difference had reduced since 1996, suggesting 
‘increasing tolerance of Cannabis in the population’ 
(p. 119). On the other hand, the author reports that, 
despite their ranking among the most harmful drugs, 
ecstasy and LSD were also among the drugs reported 
as most frequently used.
With regard to ‘gateway drugs’, respondents were asked 
whether and to what extent they agreed or disagreed 
with the statement that people who use cannabis (and 
other ‘softer’ drugs) are likely to progress onto ‘harder’ 
drugs such as heroin or cocaine. The response indicates 
that the level of agreement with this statement had 
declined since 1996.
Respondents were asked to state how much of a 
problem they thought certain drug-related activities 
were in their area (i.e. within five minutes’ walk). 
Using drugs was the most widely perceived ‘very big’ 
or ‘fairly big’ problem (45%), followed by drug-
related criminal activities, including people being 
offered drugs for sale (36%), crimes committed by 
people acting under the influence of drugs (34%) 
and thieving in order to get money to buy drugs 
(30%). Perceptions that there were ‘very big’ or ‘fairly 
big’ drug-related problems in local areas had fallen 
‘slightly but significantly’ since 1996, except for crimes 
committed by people under the influence of drugs and 
people becoming ill or dying due to the use of drugs, 
where perceptions of their seriousness had increased. 
Perceptions that there were drug-related problems 
were found to be more frequent among respondents 
in Cork City and County Kerry than in Cork County, 
among manual workers and small farmers (on 49 
acres or less) than among professional, managerial 
and business people and larger farmers (see report for 
details of social classification system used in analysis), 
and among those living in deprived urban areas. 
While 55% of respondents supported current drug 
prohibition laws, ‘quite a significant minority’ (33%) 
were of the opinion that some drugs (e.g. cannabis) 
should be legal, but with restrictions (e.g. licensing of a 
few shops/bars only). Since 1996 there had been a 12% 
increase in support for the legalisation of cannabis with 
restrictions, and a corresponding drop (14%) in support 
for continuing prohibition of all currently illegal drugs.  
Those who had ever taken drugs showed markedly 
greater support for the legalisation of cannabis and the 
relaxation of the prohibition laws, compared to those 
who had never taken drugs. 
Drugs and alcohol
Responses to a question about whether alcohol or drugs 
caused more problems in society showed a reversal of 
opinion. In 1996, 81% of respondents considered drugs 
to be an equal or greater problem than alcohol, but by 
2004 this proportion had dropped to 61%. Conversely, 
in 1996, 40% considered alcohol to be an equal or 
greater problem than illicit drugs, but by 2004 this 
proportion had grown by 27%. Disagreement with the 
statement that there is little difference in health terms 
between smoking cannabis and smoking tobacco or 
drinking alcohol had declined somewhat since 1996. 
(Brigid Pike)
1.   Jackson TMR (2006) Smoking, alcohol and drug use 
in Cork and Kerry 2004. Cork: Department of Public 
Health, HSE South.
2.   Fanagan S (2007) Repeat survey of substance use in 
Cork and Kerry. Drugnet Ireland, Issue 20: 1–2. 
3.   The sampling and research methods used in 
the study are outlined in Fanagan (2007). The 
information in this article is based on data 
gathered in the first part of the research. Field 
workers employed by TNS mrbi used a structured 
questionnaire to record responses during face-
to-face interviews with individual respondents. 
These data were coded in SPSS and subjected to 
varied statistical tests. Results from the structured 
interviews regarding respondents’ views on alcohol 
and smoking policies, their knowledge of substance 
use services and their leisure activities are not 
described in this article.
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The need for co-ordinated and integrated 
responses to the drugs problem throughout the 
country led to the establishment of the regional 
drugs task forces (RDTFs).1 To achieve a co-
ordinated response, the RDTFs were advised, when 
developing their strategies, to adopt a ‘partnership 
approach involving the statutory, voluntary and 
community sectors, through the development of 
a single, integrated plan, which all organisations 
and agencies … support and are committed to 
implementing’.2 
Although each of the 10 RDTFs has adopted its 
own distinctive mix of co-ordination tools, when 
the strategies are viewed together, the tools may be 
grouped around four main themes – governance, 
resources, communication, and service design.3
Governance
Co-ordination is as good as the decisions made by 
those responsible for planning and implementing 
the ‘single integrated plan’. The RDTFs have given 
considerable thought to means of ensuring sound 
decision-making structures and systems, i.e. good 
governance.
The task force structure is one important 
contributing factor. A ‘forum-type’ structure, 
organised around the four pillars of the National 
Drugs Strategy, with membership depending on 
the skills and information individuals can bring to 
the subject matter, has been canvassed. Various 
sub-groups to support the RDTFs by addressing 
distinct county-based, local or operational issues 
have been suggested. One RDTF proposed 
establishing an independent ‘expert group’ to 
support the evaluation of possible projects in terms 
of best practice. 
Securing the commitment of individual task force 
members is another critical factor. Members 
should be senior decision-makers in their own 
organisations, with the authority to commit 
resources, and should attend over a sufficiently 
long period to ensure continuity of knowledge and 
action. At a deeper level, ‘shared values’, enshrined 
if possible in a written agreement that also sets 
out common targets and goals, are regarded as 
important in winning the commitment of agencies 
and individual members. 
 In respect of systems, planning and evaluation 
are seen as two useful co-ordination tools. The 
RDTF strategy itself can form the framework and 
foundation for co-ordination among all involved in 
service delivery and resource provision. Evaluation 
that, among other things, helps to review and 
reflect on practice, inform further planning and 
practice, share and disseminate experiences 
and learning, and ensure resources are used 
appropriately and effectively, is also an important 
tool in sustaining a co-ordinated approach. It acts 
as a control mechanism, preventing an organisation 
from going off course or limping along ineffectually.
Resources
To be effective, co-ordination efforts need to be 
adequately resourced. Over and above core task 
force staff, one RDTF has identified the need for 15 
additional posts to provide enhanced support and 
liaison services throughout the region. One RDTF 
has called for a dedicated budget and associated 
delegations and responsibility to enable it to fund 
work addressing the drugs issue in the region. 
Communication
In line with their terms of reference, which call for 
the creation and maintenance of an up-to-date 
database on the nature and extent of drug misuse, 
and the provision of information on drug-related 
services and resources in the region,1 the RDTF 
strategies identify a variety of opportunities for the 
production and exchange of information. It is the 
communication mechanisms for the exchange of 
information, including ideas and opinions, which 
are important for ensuring effective co-ordination.
All 10 RDTFs report that they have engaged 
in extensive consultation in developing their 
strategies. This is in line with the ‘Guidelines 
for the Development of RDTF Strategy Plans’, 
which stipulate that ongoing consultation is also 
important.4 A number of RDTFs propose group 
forums to ensure that they hear on a continuing 
basis the views of different stakeholders. Forums 
of drug educators, of treatment and rehabilitation 
service providers, of service users, of parents, and 
of communities in relation to matters such as 
community policing, estate management, or issues 
relating to illicit drug use and underage drinking 
are envisaged. Community development is also 
perceived as assisting co-ordination, partly through 
involving local communities in the actions of the 
RDTF and its members, and partly through building 
capacity that will enhance the participation of 
communities in decision-making processes.
Interagency co-operation is seen as depending on, 
at minimum, an open policy of sharing information, 
such as research and models of effective practice, 
and working together to identify new solutions and 
new initiatives. Furthermore, a number of RDTFs 
have made a case for a wider advocacy and liaison 
role for the RDTFs, seeking to influence decisions 
in respect of actions that will positively impact on 
drug misuse and underage drinking, but which 
fall outside their direct sphere of influence. For 
example, some RDTFs have called for liaison or 
co-operation with other agencies, such as county 
development boards, community forums, or social 
inclusion measures working groups, in pursuit of 
common goals, or for lobbying, for example for 
community facilities. 
Tools for co-ordinating drugs initiatives 
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Service design
Two ‘clientcentric’ approaches to service design have 
been championed by various RDTFs – a case-based 
approach, and a broader approach predicated on the 
need to address drug misuse in the context of wider 
social inclusion issues. Both these approaches require 
real and effective co-ordination.
Taking their lead from Action 47 of the National 
Drugs Strategy,5 several RDTFs call for the delivery 
of case-based treatment and rehabilitation services. 
The ‘key worker’ role, supporting the service 
user through the various stages of treatment and 
rehabilitation, is seen as a necessary element of the 
case-based approach. In one RDTF strategy, the 
key worker is to be a member of a multi-agency 
group, which is to meet monthly to review cases, 
and all the agencies are to sign up to a protocol 
for working together in a case-based model. It is 
anticipated that this arrangement will lead to a co-
ordinated continuum of care for clients.
In considering drug-related service design within 
the wider framework of social inclusion policy, one 
RDTF argues that it is important to tailor service 
developments to fit the needs of groups that are 
marginalised, disadvantaged or isolated. Such 
an approach may also overcome difficulties in 
co-ordinating responses: ‘One route to tackling 
coordination problems at local level would be to 
focus on outcomes for socially excluded target 
groups and to work towards a problem-solving 
agenda where a common problem is identified 
and a strategy to address this jointly agreed.’6 This 
may include addressing ‘protective’ factors, such 
as fostering strong and healthy communities, or 
providing good social or transport infrastructure, 
as much as ‘risk’ factors, such as treatment and 
rehabilitation initiatives. 
An interesting feature of these clientcentric 
approaches to service design is the opportunity 
they afford service users, as distinct from providers, 
to drive the co-ordination effort. (Brigid Pike)
1.   Department of Tourism, Sport and Recreation 
(2001) Building on experience: National Drugs 
Strategy 2001–2008. Dublin: Stationery Office, 
Actions 92–94. 
2.   National Drugs Strategy Team (2004) 
‘Guidelines for the Development of RDTF 
Strategy Plans’. Unpublished. Dublin: National 
Drugs Strategy Team, p. 1.
3.   This survey is a sequel to the broad policy 
overview of the 10 RDTF strategies published in 
Issue 20 of Drugnet Ireland. See B Pike (2006) 
‘RDTF strategies push out boundaries’. Drugnet 
Ireland, Issue 20, pp. 11–12.
4.   National Drugs Strategy Team (2004) 
‘Guidelines for the Development of RDTF 
Strategy Plans’. Unpublished. Dublin: National 
Drugs Strategy Team, p. 3.
5.   Action 47 of the National Drugs Strategy reads: 
‘To base plans for treatment on a “continuum 
of care” model and a “key worker” approach 
to provide a seamless transition between each 
different phase of treatment. This approach will 
enhance movement through various treatment 
and aftercare forms. In addition, the “key 
worker” can act as a central person for primary 
care providers (GPs and Pharmacists) to contact 
in connection with the drug misuser in their 
care.’
6.   Western Region Drugs Task Force (2006) Shared 
solutions: First strategic plan of the Western Region 
Drugs Task Force. Castlebar: Western Region 
Drugs Task Force, p. 42.
The Ana Liffey Drug Project (ALDP) marked its 
25th anniversary with a conference on 15 March 
entitled Harm Reduction for Problem Drug 
Users. The conference was held in Trinity College 
Dublin. Among those speaking at the conference 
were Dr Tim Rhodes, Centre for Research on 
Drugs and Health Behaviour, London School of 
Hygiene and Tropical Medicine. 
In 1982 ALDP began providing a new type of 
service to drug users and their families in Dublin’s 
inner city. The values underpinning this service 
– respect, welcome, participation and right – are 
as relevant today, even though the organsiation 
has gone through a great deal of change since 
it first began to provide an alternative to the 
dominant abstinence-focused health and social 
services model. The Trinity conference looked at 
the development of ALDP over the past 25 years 
as the harm reduction approach, which originally 
placed ALDP well outside the mainstream of 
service provision, has gradually become accepted 
as a pragmatic and appropriate response to 
problem drug use in Ireland. (Brian Galvin)
ALDP has recently launched a website providing 
information on its services (www.aldp.ie/).
Ana Liffey after 25 years
Co-ordinating drugs initiatives (continued)
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The Library Association of Ireland is celebrating 
Library Ireland Week from 5–11 March 2007. 
Library Ireland Week ‘celebrates and highlights 
the role of libraries, librarians and information 
professionals’. 
A special library, by definition, maintains a more 
focused and specialised collection than traditional 
public or academic libraries. While researchers 
and practitioners based in larger organisations 
generally have access to a wide variety of library 
resources, access students and community-based 
organisations often find it difficult to locate 
specialised resources.
Many community-based organisations have 
developed substantial collections of resources 
which are generally made available to those 
who use their services. In this issue of Drugnet 
Ireland, in recognition of Library Ireland Week, 
we are featuring two specialist libraries; both are 
community based and located in Dublin. 
When someone needs help, the library is one 
of the few places where they feel comfortable. 
Going to a treatment centre may be a much 
scarier step. (Barbara Gay, Iowa Substance 
Abuse Information Centre)1
URRÚS
URRÚS is a Ballymun Youth Action Project (BYAP) 
initiative which provides training in relation to 
drug misuse. Founded in 1996, URRÚS aims to be 
a centre of learning and excellence and to develop 
and increase personal skills, effectiveness and 
employment potential. URRÚS has developed a 
range of training modules on drug abuse, addiction 
and community responses. Course participants 
include members of the community, Health Service 
Executive, community workers, gardaí, juvenile 
liaison officers and prison workers. URRÚS offers a 
range of one-day courses:
Homelessness and Drugs
Crack Cocaine
Drug Use and Stress
Other courses are offered on a part-time basis over 
a longer period of time:
Introduction to Addiction Studies
Community Addiction Studies
Diploma in Community Drugs Work (accredited 
by University College Dublin)
BYAP has recently moved to new premises in the 
Horizons Centre on Balcurris Road in Ballymun. In 
the new centre URRÚS has two dedicated training 
n
n
n
n
n
n
rooms, a dedicated library and staff offices all in 
one location. 
The URRÚS library is a unique resource which 
supports the work of URRÚS, BYAP, students taking 
courses through URRÚS and all people living, 
working and studying in Ballymun. It is a reference 
library; items cannot be borrowed, but the full 
collection is available to users on the premises. 
The collection includes government publications, 
journals and magazines, international reports, text 
books, DVDs, video, electronic documents and 
local drug awareness publications and pamphlets. 
The collection covers a wide range of addiction-
related topics, including counselling, health, family 
support, drug policy, education and training. 
Library users have access to a work station with a 
desktop computer, and an additional dedicated 
study desk. URRÚS staff are on hand to guide users 
to relevant resources.
Community Response
Community Response is a voluntary agency based 
in Dublin 8. The agency believes that the problem 
of drug use is best addressed by empowering 
individuals in the community through sharing 
knowledge, information and skills. Its training and 
education programmes include:
Certificate in Addiction Studies (provided 
at Liberties College and accredited by NUI 
Maynooth)
Behavioural studies programme (FETAC level 5)
Workshops on addiction in the home, domestic 
violence and living with AIDS
n
n
n
Libraries supporting a community 
response to addiction
Gabrielle Gilligan, (URRÚS Administrator)  
and Frantisek Anderko (library volunteer) 
in the URRÚS Library
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As well as providing substantial training and 
education programmes, Community Response 
supports a large outreach team that focuses on 
hepatitis C, HIV, health promotion, drug education, 
community development and family support.
The Community Response Library was set up in 
2002 and was dedicated to the late Tommy Larkin 
in 2006. As well as a substantial collection of text 
books, government publications, annual reports, 
newsletters, pamphlets and news clippings, the 
library holds a large collection of material on 
hepatitis and HIV. Two computer workstations are 
available to users, providing free internet access and 
printing services. Library users also have access to 
a dedicated study desk and Community Response 
staff are available to guide users through the 
available resources. The library is frequently used for 
training workshops and as a meeting venue for the 
local drugs task forces. 
Both libraries provide a wide range of addiction-
related resources and are used by the community, 
students and practitioners undertaking further 
education and training in the addictions. ‘Libraries 
are more than just books’, says Sterphanie 
Asteriadis, Nevada Prevention Resource Centre 
Coordinator (USA). ‘The more integrated they are 
into the community system, the more they can 
connect people with resources, and the better they 
serve their community.’ 1
Many thanks to Gabrielle Gilligan, Dermot King, 
Frantisek Anderko and Greg Christodoulu of URRÚS 
and to Derek Byrne, Deborah Taggart, May Peters 
and Nicola Perry of Community Response for 
welcoming me to their libraries. (Louise Farragher)
1.   Perdue M (2006) A critical need: libraries can 
play a role in helping people with substance 
abuse problems. American Libraries, 37(3): 
42–43.
URRÚS Library
URRÚS  
Horizons Centre, Balcurris Road 
Ballymun, Dublin 11 
Tel: (01) 846 7980 
Email: urrus@iol.ie 
Tommy Larkin Library
Community Response 
Carman’s Court 
14 Carman’s Hall, Dublin 8 
Tel: (01) 454 9772 
Email: commresp@iol.ie
Please telephone in advance to make an 
appointment to visit the library.
Do you have an addiction resource library?  
 
The National Documentation Centre on 
Drug Use is interested in making contact 
with you to develop an Irish network of 
addiction libraries and information centres. 
Please contact Louise Farragher by phone  
at (01) 676 1176 ext 159 or by email at 
louise@hrb.ie for further information.
Deborah Taggart and Nicola Perry of 
Community Response in the Tommy Larkin 
Library
Community addiction libraries (continued)
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Eighth annual Service of 
Commemoration and Hope 
The eighth annual Service of Commemoration and 
Hope, organised by the Family Support Network, 
was held in Our Lady of Lourdes Church on Sean 
McDermott Street on 1 February. This annual service 
is held in remembrance of loved ones lost to drugs 
and related causes and to publicly support families 
living with the devastation that drug use causes. This 
year’s service focused on the Network’s movement 
towards becoming an autonomous organisation. 
It has always been the intention that the Network 
would be run by families for families. 
Sadie Grace of the Family Support Network 
highlighted the issue of intimidation, punishment 
beatings and shooting of drug users and innocent 
people. She urged communities to co-operate with 
the gardaí and stressed that the best way to make 
communities safer to live in is to work in partnership 
with all key stakeholders in dealing with this very 
contentious issue.  The Family Support Network 
pledged its commitment to be part of this process.
Representatives from family support groups around 
Ireland attended the service. The Network would 
like to assist more family support groups to set up 
throughout the country. Ms Grace called on the 
government to deal more urgently with the drugs 
issue. She stated that if the three-year working plan 
the Network has submitted to the National Drugs 
Strategy Team is resourced, the Network will be 
able develop a professional service for families living 
with drug use throughout Ireland and continue the 
valuable work it has started.
Ruaidhri McAuliffe and Emily Reaper addressed the 
audience on behalf of UISCE (Union for Improved 
Services, Communication and Education). They 
acknowledged the role that families play in both the 
treatment of and recovery from drug addiction. They 
said that, by working together, both UISCE and the 
Network had become more aware of the problems 
facing drug users and their families.
Noel Ahern TD, Minister of State with responsibility 
for drugs strategy, and Bishop Eamonn Walshe also 
addressed the gathering. They both acknowledged 
the work and commitment of the Network and 
reiterated the importance of working in partnership to 
decrease drug-related deaths. (Ena Lynn)
The Family Support Network was established by the 
CityWide Drugs Crisis Campaign (www.citywide.ie). 
Photo: Jim Berkeley
Photo: Jim Berkeley
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As reported in issue 19 of Drugnet Ireland, the 
Research Outcomes Study in Ireland (ROSIE) released 
Findings 1 in September 2006. The study is being 
done by a team at the National University of Ireland, 
Maynooth, on behalf of the National Advisory 
Committee on Drugs (NACD). The aim of the study is 
to recruit and follow opiate users entering treatment 
and to document their progress after six months, one 
year and three years. 
At baseline, the study recruited 404 opiate users 
aged 18 years or over entering treatment or, in the 
case of a sub-sample of 26 (6%), attending needle-
exchange services. The participants were engaged in 
one of three different forms of treatment: methadone 
maintenance/reduction (53%, n=215), structured 
detoxification (20%, n=81) and abstinence-based 
treatment (20%, n=82). 
The second paper in the ROSIE Findings series 
provides a summary of the outcomes for people in 
the detoxification modality one year after treatment 
intake.1 
As the authors state, ‘structured detoxification is 
a process whereby individuals are systematically 
and safely withdrawn from opiates, under medical 
supervision’. In Ireland, the most common method 
of opiate detoxification is to use methadone and 
to reduce the dose slowly over time. Structured 
detoxification programmes are provided in both 
inpatient and outpatient settings and usually last 
between four and twelve weeks. 
The majority of the ROSIE detoxification cohort 
(n=81) was recruited from inpatient settings 
(56%, n=45), with the remainder being treated in 
outpatient settings (27%, n=22) or in prison (17%, 
n=14). The analysis presented in Findings 2 is based 
on the 62 participants who provided valid answers 
to each individual question during their treatment 
intake and one-year follow-up interviews.  
The detoxification participants were typically male 
(77%) with an average age of 26 years and were 
largely dependent on social welfare payments 
(73%). Just less than half (47%) had children but the 
majority (62%) of these did not have their children in 
their care. Most had spent some time in prison (70%) 
and 11% had been homeless in the 90 days prior to 
treatment intake interview. 
Treatment completion rates
The treatment completion rate was high, with 
68% of participants successfully completing their 
detoxification programme (n=42). Just over one-
quarter of the cohort (27%, n=17) dropped out 
of treatment and the remaining 5% (n=3) were 
transferred to another treatment type before 
completing the programme.
One year after treatment intake, 73% of participants 
(n=45) reported that they were in some form of 
drug treatment. Forty-two per cent (n=26) were on a 
methadone programme, 34% (n=21) were attending 
one-to-one counselling and 24% (n=15) were 
attending group work (Narcotics Anonymous (NA) 
meetings, aftercare programmes and structured day 
programmes). 
Drug-use outcomes
The number of participants who reported using 
heroin, non-prescribed methadone, non-prescribed 
benzodiazepines, cocaine, cannabis or alcohol in 
the 90 days prior to interview decreased between 
treatment intake and one-year follow-up. The most 
substantial reduction was in heroin use, both in terms 
of the proportion of participants using the drug (79% 
at treatment intake compared with 39% at one year) 
and the frequency of use (an average of 38 out of 90 
days at treatment intake compared with an average 
of 14 out of 90 days at one year). 
Reported illicit drug abstinence rates increased 
from 8% at treatment intake (n=5) to 45% at one 
year (n=28). Abstinence from all drugs (including 
prescribed methadone) increased from 5% at 
treatment intake (n=3) to 39% at one year (24).  
Crime outcomes
Overall, the proportion of participants who reported 
no involvement in crime had risen considerably 
at one year (75%) compared to treatment intake 
(19%). There was a reduction in the percentage of 
participants involved in acquisitive crime, from 35% 
(n=21) at treatment intake to 7% (n=4) at one year. 
Risk-behaviour outcomes
Findings 2 reports a reduction in the number of 
participants who reported injecting drug use. At 
treatment intake 48% (n=30) of the cohort had 
injected a drug in the 90 days prior to interview, 
compared with 23% (n=14) at one year. A statistically 
significant decrease in injecting was reported for 
heroin and cocaine. There were no changes in 
participants’ injecting-related risk behaviours. The 
proportion of participants who reported an overdose 
within the previous 90 days reduced from 5% (n=3) 
at treatment intake to 0% at one year. However, one 
participant from the detoxification modality died 
before the one-year follow-up. This is thought to 
have been due to an overdose but the cause of death 
has not yet been independently confirmed.  
Health outcomes
Ten symptoms were used to measure the physical 
health of participants (see paper for details). The 
number of participants who reported seven of the 
ten physical health symptoms reduced between 
treatment intake and one year. As would be 
expected, there was a reduction in the number of 
ROSIE Findings 2: summary of 
detoxification treatment outcomes
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participants reporting opiate withdrawal symptoms 
between treatment intake and one year. 
Ten symptoms were also used to measure the 
mental health of participants (see paper for details). 
There was a reduction in the number of participants 
who reported suffering from any five of the ten 
mental health symptoms. Most of the reductions 
were in anxiety-related symptoms. While there 
were reductions in the remaining depressive-
type symptoms, the results were not statistically 
significant.
Service contact
Findings 2 reports an increase in participants’ contact 
with three social care services between treatment 
intake and one year. The proportion of participants 
contacting social services increased from 2% to 10%, 
those using employment/education services rose from 
13% to 35% and the proportion contacting housing/
homeless services increased from 19% to 23%.
The authors state that the findings presented in 
this paper demonstrate that participation in a 
detoxification programme is followed by reduced 
drug use and injecting, decreased involvement in 
crime, improved physical and mental health and 
increased contacts with social care services. The 
outcomes for ROSIE participants in detoxification 
treatment are positive when compared with national 
and international research. As noted in the paper, 
detoxification is part of a process that enables 
individuals to engage in further treatment (such as 
residential rehabilitation). Additional analysis of the 
ROSIE data is required in order to determine the 
effects of aftercare or follow-on interventions on 
treatment outcomes for those who have successfully 
completed a detoxification programme.  
(Sarah Fanagan)
1.  Cox G, Comiskey C and Kelly P (2007) ROSIE 
Findings 2: Summary of 1-year outcomes: 
detoxification modality. Dublin: National Advisory 
Committee on Drugs.
ROSIE Findings 2 (continued)
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Young Scientist codeine study wins HRB prize
Aine Keating and Annie McCole from Coláiste Ailigh, 
Donegal, won the Health Research Board prize for 
the best health-related project at the BT Young 
Scientist Exhibition held in January 2007 at the RDS 
in Dublin.
The aim of their project was to highlight the 
ongoing problem of codeine addiction in Ireland. 
They contacted 120 pharmacies in Dublin, and 
in the west and north-west of Ireland, of which 
83% responded to their survey. One hundred 
questionnaires were analysed. They interviewed 
two pharmacists and contacted various interest 
groups, including the Irish Pharmaceutical Union, 
the Irish Medicines Board, Cork University and 
GlaxoSmithKline.
Results of their survey show that soluble Solpadeine, 
which contains codeine, is the most common non-
prescription medical product sold in the pharmacies 
surveyed, followed by Neurofen Plus, which also 
contains codeine.
The majority of pharmacists surveyed (94%) believed 
that some customers, estimated at an average of four 
per day, who purchased products containing codeine 
were addicted to codeine. Seventy-two per cent of 
the pharmacists would like to see a change in the 
legislation to limit the quantity of codeine that can 
be sold over the counter.
As a result of their survey, the students concluded 
that ‘codeine addiction is a widespread problem 
around Ireland’. (Ena Lynn)
Dr Mairéad O’Driscoll (HRB) presents the prize for the best health-related project at the BT Young 
Scientist Exhibition 2007 to Aine Keating and Annie McCole from Coláiste Ailigh, Donegal.
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According to the Health Protection Surveillance Centre 
(HPSC) annual report for 2005,1 there were 1,439 cases of 
hepatitis C reported in 2005, compared to 1,154 cases in 
2004,2 and 85 cases of hepatitis ‘type unspecified’3 in 2003. 
Of the cases reported in 2005, over 70% were notified by 
services in Dublin, Kildare and Wicklow and the remainder by 
HSE areas outside these counties. Age-standardised hepatitis 
C rates per 100,000 of the population living in each former 
health board area were calculated for 2004 and 2005 (Figure 
1). In 2005, the rate was highest in the Eastern Region (at 
69 per 100,000) and lowest in the North West (at 2 per 
100,000). The rate of hepatitis C cases per 100,000 of the 
population increased in each of the former health board 
areas. Sixty-four per cent of hepatitis C cases reported were 
male. Of the cases for whom age was known, 80% were 
aged between 20 and 44 years. Data from blood-borne viral 
prevalence studies indicate that around 70% of injecting drug 
users attending drug treatment tested positive for antibodies 
to the hepatitis C virus.4 Injecting practices and prison history 
are associated with hepatitis C status. 
It is proposed to introduce an enhanced surveillance system 
for hepatitis C in Ireland in 2007. Enhanced surveillance is 
essential to identify risk factors and for planning prevention 
and treatment strategies. Risk-factor identification is required 
to fulfil the basic requirements of the European Monitoring 
Centre for Drugs and Drug Addiction key indicator on drug-
related infectious diseases. 
In 2004, an enhanced surveillance system was introduced 
to monitor risk populations diagnosed with acute or 
chronic hepatitis B. The number and proportion of chronic 
cases for whom risk-factor data were reported were very 
low in 2004 and 2005. Of those for whom risk-factor 
data were reported, the numbers reporting injecting 
drug use were very small (Table 1). These low numbers 
could indicate that an effective immunisation programme 
prevented many injecting drug users from contracting 
hepatitis B, or that drug treatment service providers were 
not aware of the need to report the risk factor status of 
chronic hepatitis B cases. The situation is likely to be due 
to a combination of both factors as one in five injecting 
drug users has hepatitis B, while, on the other hand, many 
injecting drug users in Dublin receive hepatitis B vaccine.4  
(Jean Long)
1.   Health Protection Surveillance Centre (2006) Annual 
report 2005. Dublin: Health Service Executive.
2.   Health Protection Surveillance Centre (2005) Annual 
report 2004. Dublin: Health Protection Surveillance 
Centre.
3.   Disease category under which hepatitis C cases were 
notified up to the end of 2003.
4.   Long J (2006) Blood-borne viral infections among injecting 
drug users in Ireland, 1995 to 2005. Overview 4. Dublin: 
Health Research Board.  
Hepatitis surveillance in 2005
0
10
20
30
40
50
60
70
80
0
10
20
30
40
50
60
70
80
E M MW NE NW SE S W
A
SI
R
 p
er
 1
00
,0
00
 p
op
ul
at
io
n
2004
2005
Figure 1    Age-standardised infection rates of hepatitis C per 100,000 population, by HSE area, 2004 and 2005
Source: HPSC (2006)
Table 1    Number (%) of acute and chronic hepatitis B cases reported to the HPSC, by risk factor 
status, 00 and 00
 Hepatitis B status
Acute Chronic 
2004
Unknown 
 
Acute Chronic 
2005
Unknown
Risk factor status  No.  No.  No.  No.  No.  No. 
Total number of cases  57  497  169  74  706  124
Cases with reported risk factor data  36  95  1  49  185  13
       Of which:
       Injecting drug users  57  0  0  0  3  1
Cases without reported risk factor data  21  402  168  25  521  111 
Source: Unpublished data from the HPSC
(2.8)
(36.8)
(0.0)
(80.9)
(0.0)
(99.4)
(0.0)
(33.8)
(1.6)
(73.8)
(7.7)
(89.5)
(%) (%) (%) (%) (%) (%)
In November 2006 the National Treatment Agency 
for Substance Misuse in the UK published a report 
reviewing the effectiveness of treatments for alcohol 
problems.1 
Alcohol use exists along a continuum from problem-
free use to very harmful and dependent use. A 
significant proportion of those who develop alcohol 
problems in the general population recover without 
formal treatment, but by responding to support and 
direction from family and friends or to self appraisal 
of the problem drinking. Those who seek treatment 
have typically experienced prolonged alcohol-related 
problems in health, relationships and finances and 
have had previous, failed, unassisted attempts at 
changing drinking behaviour. 
Traditionally, alcohol treatment has had a narrow 
focus, concentrating on ‘alcoholics’ or those with 
severe alcohol dependence. It is now recognised 
that this exclusive focus needs to be broadened to 
include the large group of drinkers whose problems 
are less severe. Early intervention, before excessive 
drinking has produced a level of alcohol dependence 
that renders treatment difficult, is associated with 
better outcome and cost effectiveness. Treatments 
for harmful and hazardous drinkers may involve 
providing brief treatment or information and 
advice in an out-patient setting, whereas treatment 
for problem or dependent drinkers may involve 
complicated detoxification in residential settings 
(Figure 1).
Early detection is essential to identify problem 
drinkers who have not sought help, and targeted 
rather than universal screening is recommended. 
Screening instruments include questionnaires, 
biological markers of recent alcohol consumption 
and clinical indicators using clinical history or signs 
at physical examination. The AUDIT (Alcohol Use 
Disorders Identification Test) questionnaire has good 
sensitivity and specificity for detecting hazardous and 
harmful drinking and has been validated for use in a 
wide range of settings and populations. 
The types of treatment available can be categorised 
into three groups – psychosocial treatment, 
non-alcohol-focused specialist treatment and 
pharmacotherapies. Psychosocial treatments typically 
focus on helping clients both to develop better 
skills and to improve their environment, and those 
with a clear structure and well-defined interventions 
have positive effects on alcohol problems. Non-
alcohol-focused specialist treatments include coping 
skills, counselling, family work and complementary 
therapies and have a strong evidence base. 
Pharmacotherapies treat alcohol problems with 
drugs, including detoxification medications, relapse-
prevention medications and nutritional supplements. 
Alcohol treatments:  
review of effectiveness
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Figure 1    A spectrum of responses to alcohol problems
Source: Rastrick et al. (2006),1 adapted from Institute of Medicine (1990).2
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The Mesa Grande is a type of league table based on 
accumulated evidence of treatment effectiveness 
from controlled trials and is useful as a broad 
indicator of which treatments are supported by 
research evidence. The treatments deemed most 
effective by this method fall mainly under the 
heading of ‘cognitive-behavioural therapy’, a 
psychosocial treatment based on social learning 
therapy. There is strong evidence for the effectiveness 
of this therapy among those with severe drinking 
problems. Two kinds of pharmacotherapy are also 
well supported by research evidence – acamprosate 
and naltroxone – but are best regarded as adjuncts to 
psychosocial treatment.
Brief interventions are given the highest rank in the 
Mesa Grande and are directed at hazardous and 
harmful drinkers who, typically, are not complaining 
about or seeking help for an alcohol problem. They 
are carried out in general community settings and 
are delivered by non-specialist personnel. Brief 
interventions, of various forms and delivered in a 
variety of settings, are effective in reducing alcohol 
consumption to low-risk levels, but most healthcare 
professionals have yet to incorporate screening 
and brief interventions for hazardous and harmful 
drinking into their routine practices.
Less intensive treatments are aimed at help-seekers 
and are usually delivered by specialist workers in 
alcohol treatment agencies. They are intended 
mainly for moderately dependent drinkers and 
are cheaper to deliver than conventional, more 
intensive treatments. These treatments often involve 
the participation of relatives and friends in the 
treatment process. Examples of such treatments 
include motivational interviewing, motivational 
enhancement therapy, brief conjoint marital therapy 
and condensed cognitive behavioural therapy. 
Motivational enhancement therapy is ranked second 
in the Mesa Grande.
For service users with moderate or severe alcohol 
dependence, alcohol-focused treatments in specialist 
alcohol or addiction services are most appropriate. 
The cognitive behavioural family of interventions 
is well researched and is shown to be effective 
for this group of service users. These treatments 
concentrate on the service user’s drinking and 
alcohol-related problems and are best deployed in 
community settings where the service user has the 
opportunity to try out newly learned behaviour in 
the real environment and get immediate feedback 
on performance. Examples include community 
reinforcement approach, social behaviour and 
network therapy, behavioural self-control training and 
coping and social skills training. 
Pharmacotherapies are generally targeted at a narrow 
spectrum of symptoms or psychological problems 
and are usually insufficient to constitute a treatment 
package when given alone. Pharmacotherapies, when 
combined with psychosocial therapies, consistently 
improve addiction outcomes. Detoxification is a 
common procedure which may be undertaken in any 
treatment setting and chlordiazepoxide is the drug 
of choice for uncomplicated detoxification. Relapse-
prevention medication includes sensitising agents 
which produce an unpleasant reaction when taken 
with alcohol, and anti-craving medications which act 
upon endogenous neurochemical systems to reduce 
alcohol cravings. An example of a sensitising agent 
is disulfiram, while naltrexone and acamprosate are 
examples of anti-craving medications. 
There is no best treatment or intervention for 
alcohol problems. Rather, there is a range of 
effective treatments for different types of service 
user in different settings. People whose problems 
are more complex by virtue of severe dependence, 
psychological morbidity or social disorganisation 
are likely to need more intensive treatments. The 
selection of which treatment to offer therefore 
depends on clinician preference, client choice and 
availability of trained and enthusiastic therapists. 
Effective treatment requires a delivery system that 
has the following three components: organisational 
support to clinical services, well-trained therapists 
and a repertoire of specific interventions that meet 
service users’ needs. The stepped-care model of 
treatment represents a cost-effective implementation 
of treatment services. The basic principle of this 
approach is that alcohol misusers are initially offered 
the least intrusive and least expensive intervention 
that is likely to be effective.
Providing effective treatment is likely to significantly 
reduce the social costs relating to alcohol as well as 
improving individual social welfare. The variation 
in the course of alcohol problems over time means 
it is a better investment to spend fewer healthcare 
resources during each contact with the service user, 
while allowing the intervention to extend over 
a longer period. Although healthcare costs may 
increase in the short term for drinkers who have 
not accessed healthcare services prior to alcohol 
treatment, they are likely to decrease thereafter. It is 
claimed that for every £1 spent on treatment in the 
UK, £5 is saved elsewhere, making alcohol treatment 
highly cost effective in comparison with other 
healthcare interventions. (Deirdre Mongan)
1.   Raistrick D, Heather N, Godfrey C (2006) 
Review of the effectiveness of treatment for alcohol 
problems. London: National Treatment Agency for 
Substance Misuse.
2.   Institute of Medicine (1990) Broadening the base 
of treatment for alcohol problems. Washington DC: 
National Academies Press, Figure 9.1.
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Introduction
Cocaine is a central nervous system stimulant that leads to 
immediate but short-term euphoria, alertness and a sense of 
well-being. It may also reduce anxiety and social inhibitions 
while increasing energy and self-esteem. For the user, the 
desire for the positive short-term effects of cocaine often 
overrides concern about the longer-term consequences 
of acquiring and using the drug. Cocaine dependence 
is a common and serious condition which has become 
a substantial public health problem. There is a wide and 
documented range of consequences associated with chronic 
use of cocaine, such as medical, psychological and social 
problems. 
On 3 May 2006 the Heath Service Executive (HSE) organised 
a workshop on cocaine. Dr Brion Sweeney, clinical director 
of the HSE Northern Area Addiction Services, presented the 
evidence base for the treatment of problem cocaine use and 
stated that cognitive behavioural therapy in conjunction 
with other interventions was the most successful form of 
treatment. He went on to state that prompt, accessible and 
tailored interventions increased the effectiveness of such 
treatment. He pointed out that the evidence indicated that 
medication had limited effect in the treatment of cocaine 
dependence, but said that new developments were expected 
in this area. 
This article presents details of the summary evidence 
presented at the workshop. Where possible, the evidence 
is based on systematic reviews.1 A systematic review is 
an overview of primary studies that used explicit and 
reproducible methods. 
Indicators
The indicators used to measure the success of treatment for 
problem cocaine use are: the absence of drug metabolites in 
the urine during and following treatment; retention in and 
completion of treatment interventions; and attendance at 
aftercare. 
Treatment
Therapeutic management of people addicted to cocaine 
is based on abstinence from cocaine use. In the initial 
period following cessation, the person being treated may 
experience an intense craving for cocaine, and symptoms 
such as depression, fatigue, irritability, anorexia and sleep 
disturbance. The past decade has seen a sustained search 
for an effective medication for the management of cocaine 
dependence. 
Medications
A number of studies have concentrated on finding a 
medicine to alleviate depression associated with cocaine 
use and to reduce cocaine craving. Lima and colleagues2 
completed a systematic review of 18 randomised control 
trials on the use of antidepressants in treating cocaine 
dependence. The authors found that trials had not shown 
that antidepressants helped reduce cocaine dependence, 
although this might have been partly because many 
people stopped using the antidepressants too early. More 
people might have benefited if they had continued to use 
antidepressants for an appropriate period of time. The 
findings and recommendations were similar for cocaine users 
who were also dependent on heroin or were on methadone 
programmes. Individuals attending methadone treatment 
programmes may benefit from supervised consumption of 
anti-depressants and this approach should be tested using an 
appropriate research method.
Because chronic use of cocaine decreases dopamine 
concentrations in the brain, it was thought that 
pharmacological treatment that controlled dopamine levels 
could theoretically reduce these symptoms and contribute 
to a more successful therapeutic approach. Soares and 
colleagues3 evaluated the efficacy and acceptability of 
dopamine agonists for treating cocaine dependence 
through a systematic review of 17 studies. The authors 
reported that dopamine agonists had been used for reducing 
the symptoms that patients experienced during the initial 
period of abstinence from cocaine. This review of trials found 
that the evidence of success was not adequate to support 
the use of dopamine agonists as a treatment for cocaine 
dependence.
The anti-convulsant carbamazepine (a tricyclic medication 
that is widely used to treat a variety of neurological and 
psychiatric disorders) has been used for treatment of cocaine 
dependence. Lima-Reisser and colleagues4 examined 
whether carbamazepine was effective in the treatment of 
cocaine dependence through a systematic review of five 
studies. The review of trials found that carbamazepine had 
not been shown to help reduce cocaine dependence. The 
drop-out rate from treatment was high, adverse effects were 
common, and there was no significant fall in the participants’ 
cocaine use.
Silva de Lima and colleagues5 reviewed the efficacy of 
pharmacotherapy in treating cocaine dependence. The 
drug treatments included in the trials were grouped into 
the following categories: antidepressants, carbamazepine, 
dopamine agonists, and miscellaneous other drugs. The 
miscellaneous treatments included naltrexone, mazindol, 
lithium, disulfiram, phenytoin, nimodipine, lithium 
carbonate, NeuRecover-SA and risperidone. The effects 
of these drugs were compared with each other or with a 
placebo. Seven studies were included in the review. The 
authors concluded that there was no current evidence to 
support the clinical use of most of these drugs, including 
disulfiram, in the treatment of cocaine dependence. 
Acupuncture
Auricular acupuncture (insertion of acupuncture devices into 
a number of specific points in the outer ear) is a widely used 
treatment for cocaine dependence. Gates and colleagues6 
assessed its effectiveness in a review of seven study trials, all 
of which were of low methodological quality. The review 
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found no evidence that auricular acupuncture was effective 
in the treatment of cocaine dependence. High-quality 
randomised trials of auricular acupuncture may be justified. 
Therapeutic communities
Therapeutic communities are a popular treatment for the 
rehabilitation of drug users in the USA and Europe. In a 
review of seven studies, Smith and colleagues7 examined the 
effectiveness of therapeutic communities compared to other 
treatments for substance misusers, and investigated whether 
their effectiveness was modified by client or treatment 
characteristics. Differences between the studies reviewed 
precluded any pooling of data; results were summarised 
for each trial individually. The authors concluded that there 
was little evidence that therapeutic communities offered 
significant benefits in comparison with other residential 
treatments, or that one type of therapeutic community 
was better than another. There was some evidence of 
reduced re-offending among prisoners who had participated 
in therapeutic communities while in prison. However, 
methodological limitations may have introduced bias to the 
studies, and firm conclusions could not be drawn due to the 
limitations of the existing evidence.
Cognitive behavioural therapy
Cognitive behavioural therapy is a system of psychotherapy 
which attempts to reduce excessive emotional reactions 
and self-defeating behaviours by modifying underlying 
erroneous thinking and maladaptive beliefs. According to 
experts in this area, the cognitive approach, when applied 
to substance abuse, helps individuals deal with the problems 
leading to emotional distress and gain a better perspective 
on their reliance on drugs. Specific cognitive strategies are 
said to help individuals establish stronger internal controls 
and reduce their urges to take drugs. In addition, cognitive 
therapy can help patients to combat depression, anxiety or 
anger, which increase addictive behaviours. 
Since there were no systematic reviews in the Cochrane 
Library that examined the evidence of effectiveness 
of psychotherapeutic interventions (such as cognitive 
behavioural therapy) in the treatment of cocaine 
dependence, some individual studies were reviewed for the 
purposes of this article. 
Crits-Christoph and colleagues8 examined combinations 
of psychosocial treatments for cocaine dependence. They 
compared four different treatments – cognitive therapy, 
psychodynamic therapy, individual drug counselling, and 
group drug counselling alone. The first three treatments 
mentioned included group drug counselling along with the 
specific individual therapy. Treatments were intensive and 
provided over a six-month period. The clients were followed 
up at six and at twelve months. The authors found that, 
when compared to the two forms of psychotherapy and to 
group drug counselling alone, individual drug counselling 
plus group work showed the greatest improvement in 
the number of days the clients did not use cocaine over 
a one-month period. The authors were surprised by this 
finding because in 1991 Carroll and colleagues9 reported 
that relapse-prevention therapy (a form of cognitive 
behaviour therapy) was more effective than interpersonal 
psychotherapy, and had higher abstinence and recovery 
rates. In 1994, Higgins and colleagues10 reported that relapse 
prevention therapy with the addition of incentives was more 
effective than relapse prevention therapy alone. The clients 
who received incentives were more likely to complete their 
treatment and had a longer duration of cocaine-negative 
urines. Crits-Christoph and colleagues reviewed the evidence 
from the earlier studies mentioned and pointed out that the 
counsellors selected to participate in their study followed 
a detailed manual and provided intensive counselling with 
a strong focus on drug abstinence. They reported that 
psychotherapy was more effective in clients with psychiatric 
symptoms, and pointed out that their own study involved 
a relatively small number of such clients. In a follow-up 
analysis of the same cohort,11 the authors noted that there 
was no difference between the four types of treatment in 
other important measures of success, such as psychiatric 
symptoms, alcohol use and employment rates, nor in relation 
to interpersonal, social and family issues.
Brief intervention
Bernstein and colleagues12 conducted a randomised control 
trial to determine whether brief motivational counselling was 
more effective that written information in reducing cocaine 
use among clients attending an outpatient clinic in Boston. 
Six months following intervention, they found marginally 
higher rates of abstinence among those who attended brief 
motivational counselling than among those who received 
written information. For those reporting both cocaine and 
opiate use, the abstinence rates were 22% among those 
who were given brief motivational counselling, compared 
to 17% among those who received information; among 
cocaine users, the corresponding abstinence rates were 
17% and 13% respectively. It is interesting to note that 
providing information on cocaine itself and its associated 
treatment options did encourage some respondents to seek 
help. Indeed, despite the title of this paper, the differences 
in abstinence rates for the two interventions were neither 
clinically nor statistically significant.
Vaccine
Hall and Carter13 state that ‘a cocaine vaccine is a 
promising immunotherapeutic approach to treating cocaine 
dependence which induces the immune system to form 
antibodies that prevent cocaine from crossing the blood 
brain barrier to act on receptor sites in the brain. The most 
promising application of a cocaine vaccine is to prevent 
relapse to dependence in abstinent users who voluntarily 
enter treatment’. Two published studies examined the use of 
cocaine vaccine among human populations.14,15 Both studies 
showed some promising results; however, general availability 
of a cocaine vaccine is not imminent.
Management of cocaine dependence in the UK
The Drug Treatment Agency (DTA) in the UK emphasises 
a number of key practices which improve the success of 
cocaine treatment. According to the DTA, once the initial 
contact with a treatment service is made, rapid intake, 
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proactive reminders, and practical help with attendance 
improve treatment uptake rates. Once cocaine users start 
treatment, they tend to stay longer and respond better if 
they feel that their concerns are being positively addressed 
and that their key worker is empathic and understanding. 
This indicates the crucial role that key workers play in 
motivating and retaining clients. 
The above evidence and experience indicate that the 
following strategies would help cocaine users manage their 
dependence:
Ensure seamless pathways through a four-tier service 
with clear strategies at each level.
Provide information or brief intervention at accident 
and emergency, harm reduction and opiate treatment 
services. The information should cover the dangers of 
cocaine use, the symptoms of dependence and the 
treatment services available.
Once contact is made with treatment services, ensure 
rapid intake, provide proactive reminders, and give 
practical help with attendance.
Complete an assessment of the client’s situation and 
needs.
Address the client’s immediate concerns and practical 
needs. 
Assign a key worker who is empathic and 
understanding.
Develop basic criteria for assigning clients to either 
cognitive therapy or individual counselling.
Ensure that extensive training and detailed manuals are 
available for those providing therapy and counselling 
(examples on the US National Institute on Drug Abuse 
website (www.nida.nih.gov).
Enhance compliance with anti-depressant medication 
through directly observed treatment approaches and 
by dealing with complications as soon as possible.
Consider the provision of incentives for particular client 
groups if and when necessary.
Provide complementary therapies to enhance the 
client’s’ well-being, rather than dealing solely with their 
addiction.
Include interventions implemented to address problem 
cocaine use in surveillance systems and research 
projects so as to add to the existing evidence base. 
(Jean Long and Eamon Keenan)
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The latest annual report from the National Psychiatric  
In-patient Reporting System (NPIRs) on activities in 
psychiatric inpatient units and hospitals shows that the total 
number of admissions to inpatient care has continued to 
fall.1 The report, Activities of Irish psychiatric units and hospitals 
2005, was published in November 2006 by the Health 
Research Board (HRB) and is the latest in a series that began 
more than forty years ago.
In 2005, there were 2,995 cases admitted with an alcohol 
disorder, of whom 962 were treated for the first time.1 Figure 
1 presents the rates of first admissions to inpatient psychiatric 
services between 1990 and 2005 with a diagnosis of alcohol 
disorder, per 100,000 of the population.1-4 It is notable that 
the rate decreased steadily between 1991 and 2004 and 
more than halved during the reporting period. The rate 
of new admissions stabilised in 2005. The trend since the 
early nineties reflects changes in alcohol treatment policy 
and practice during the period and the resultant increase in 
community-based and special residential alcohol treatment 
services. Of the 3,007 discharges with an alcohol disorder, 
just under 43% spent less than one week in hospital and 
17% spent more than one month in hospital.
In 2005, there were 777 cases admitted with a drug disorder, 
of whom 308 were treated for the first time.1 There are no 
data presented in the report on psychiatric co-morbidity. 
Figure 2 presents the rates of first admissions to inpatient 
psychiatric services between 1990 and 2005 with a diagnosis 
of drug disorder, per 100,000 of the population.1-4 It is 
notable that the rate increased steadily between 1990 and 
1995, with a dip in 1996, and further annual increases 
between 1997 and 2001. The rate was almost three times 
higher in 2001 than it was in 1990. The dips in 1996 and 
2002 can be partly explained by the fact that the rates are 
calculated from new, larger census numerators in 1996 
and 2002 compared to the year preceding each of these 
years. The small number of drug dependence cases each 
year would be sensitive to this change in numerator. The 
increasing rate of new cases of drug-related admissions 
between 1990 and 2001 reflects the increase in problem 
drug use in Ireland and its burden on the psychiatric services. 
There was a notable decrease in 2002, which was sustained 
in 2003. This overall decrease since 2001 possibly reflects 
an increase in community-based specialised addiction 
services during this period. The increased rate in 2005, partly 
accounted for by the diminishing denominator in the 2002 
census, may reflect a failure of community-based specialised 
addiction services in Dublin to deal with drugs other than 
opiates, and of community-based specialised addiction 
services outside Dublin to deal with opiate users. Of the 818 
discharges with a drug disorder, just under 45% spent less 
than one week in hospital and just over 19% spent more 
than one month in hospital. (Jean Long)
1.   Daly A, Walsh D, Ward M and Moran R (2006) Activities 
of Irish psychiatric units and hospitals 2005. Dublin: Health 
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and hospitals 2004. Dublin: Health Research Board.
4.   Walsh D and Daly A (2004) Mental illness in Ireland 
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Figure 2   Rates of psychiatric first admissions with a 
diagnosis of drug disorder (using the ICD-10 three 
character categories) per 100,000 of the population in 
Ireland and reported to the NPIRS, 1990 to 2005
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Figure 1   Rates of psychiatric first admissions with a 
diagnosis of alcohol disorder (using the ICD-10 three 
character categories) per 100,000 of the population in 
Ireland and reported to the NPIRS, 1990 to 2005
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Determining whether research findings have influenced 
policy and practice is not easy. A recent publication by the 
Pompidou Group of the Council of Europe attempts to 
address this issue in relation to drug treatment demand 
data.1
The Pompidou Group has advocated the systematic 
and routine collection of information on clients entering 
treatment for problem drug use (treatment demand 
data) since the mid-1980s. During the early 1990s the 
Pompidou Group developed and tested a standard 
set of core data to be collected on a routine basis 
from drug treatment providers, using comparable 
procedures and criteria. As a result of this early work, 
a treatment demand protocol was developed and 
implemented in many European countries, while in other 
countries existing systems were adapted to become 
as comparable as possible with the Pompidou Group 
methodology.2 The protocol and the experience gained 
through its application served as a starting point for the 
harmonisation of the treatment demand indicator in the 
EU by the European Monitoring Centre for Drugs and 
Drug Addiction.
Given that treatment demand data have been collected 
in many European countries for the best part of two 
decades, it is understandable that questions should be 
asked about how these data have been used to influence 
policy and practice development. The Pompidou Group 
publication takes a very pragmatic approach to answering 
this question. In order to establish the link between the 
use of treatment demand data and a subsequent policy or 
practice decision, it was necessary to have documentary 
evidence to support the connection. For example, a policy 
recommendation had to be supported or based on the 
findings of treatment demand data and a reference to this 
effect had to be evident in the relevant policy document.
Three case studies, one each from Ireland, Italy and 
Slovenia, are provided to illustrate this documentary link. 
The Irish case study is described below.
In July 1996, the Irish Government set up a Ministerial 
Task Force to review the measures to reduce the demand 
for drugs and, in the light of that review, to recommend 
changes in policy, legislation or practice to facilitate more 
effective drugs reduction strategies.  In its first report,3 
published in October 1996, the Task Force recognised 
that Ireland’s drug problem was primarily an opiates 
problem – mainly heroin – and, further, that Ireland’s 
heroin problem was principally a Dublin phenomenon. 
Using maps produced by the Health Research Board’s 
drug treatment reporting system showing the areas of 
residence of those receiving treatment for drug misuse in 
the greater Dublin area in 1995, the Task Force identified 
10 local areas where the heroin problem was most 
acute. An additional, eleventh, area was identified in 
Ireland’s second major city, Cork. It was noted that there 
was a high correlation between these areas and areas 
of economic and social disadvantage. The Task Force 
concluded that ‘in view of the link between economic 
and social deprivation and drug misuse, strategies to deal 
with the problem need to be focused on these areas’. As 
a result, the Task Force recommended a series of drugs 
initiatives, one of which was the establishment of local 
drugs task forces comprising statutory, voluntary and 
community representatives, in each of the eleven worst-
affected areas. Each local drugs task force was mandated 
to draw up a profile of all existing or planned services and 
resources available in the area to combat the drugs crisis 
and to agree a development plan to build on these. 
The Government accepted the recommendations 
contained in the first report of the Ministerial Task Force 
and local drugs task forces were set up in 1997.  In its 
second and final report, published in May 1997, the 
Ministerial Task Force identified a further two worst-
affected areas in Dublin and recommended that local 
drugs task forces should be established in these areas 
also.4 
Today, local drugs task forces provide a mechanism 
through which local communities are able to work 
closely in partnership with the statutory sector to tackle 
local drug problems. Indeed, it is recognised that a 
critical factor in the success of the whole process was 
the involvement of local community groups since they 
‘brought to the table the most direct knowledge of the 
drugs issue at a local level and the most direct stake in 
improving the situation.’5
Local and, more recently, regional drugs task forces 
continue to use data from the National Drug Treatment 
Reporting System to monitor the drug situation in their 
areas and to plan services. (Hamish Sinclair)
1.  Sinclair H (2006) Drug treatment demand data: influence 
on policy and practice. Strasbourg: Council of Europe.
2.   Stauffacher M and Kokkevi A (1999) The Pompidou 
Group treatment demand protocol: the first pan-
European standard in the field. European Addiction 
Research, 5: 191–6.
3.   Ministerial Task Force on Measures to Reduce the 
Demand for Drugs (1996) First report of the Ministerial 
Task Force on measures to reduce the demand for drugs. 
Dublin: Department of the Taoiseach.
4.   Ministerial Task Force on Measures to Reduce the 
Demand for Drugs (1997) Second report of the 
Ministerial Task Force on measures to reduce the demand 
for drugs. Dublin: Department of the Taoiseach.
5.   PA Consulting Group (1998) Evaluation of drugs 
initiatives. Department of Tourism, Sport and 
Recreation. Final report. Dublin: PA Consulting Group 
(unpublished).
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Recent research by Mayock and Vekic (2006)1 
presents data from the first phase of a two-phase 
longitudinal cohort study of young homeless 
people living in the Dublin metropolitan area. The 
research focused on young people living in Dublin 
for at least six months prior to the commencement 
of the study. The study used ‘life history’ interviews 
with 40 young people recruited through homeless 
services and street settings. In qualitative research 
when this method is used, interviewees are invited 
to tell their ‘life stories’, then the researcher invites 
them to explore in depth significant life events that 
are broadly related to the aims of the research. The 
aim of this technique is to uncover as far as possible 
the interviewees’ interpretations of significant life 
events and to allow them to elaborate on issues 
that may not have figured in the initial research 
aims but nonetheless are viewed as relevant to the 
research. 
The interviews were conducted between 
September 2004 and February 2005. Fifty per 
cent of the cohort was aged between 15 and 17 
years. Nineteen of the cohort reported becoming 
homeless initially at the age of 14 or younger, while 
12 initially became homeless at age 15. This would 
suggest that the early to mid-teen years is a period 
of great risk for becoming homeless. 
The research identified three broad pathways into 
homelessness for the study cohort. The authors 
caution against interpreting these pathways as 
‘causes of homelessness’, suggesting that they be 
viewed rather as key circumstances and experiences 
that appeared to push the young people towards 
homelessness. 
Household instability and family conflict 
of varying degrees figured largely in the 
experience of most of these young people from 
an early age. For example, parental discord 
and/or marital breakdown, the presence of 
a step-parent and parental alcohol and drug 
abuse figured prominently in the events leading 
to that initial experience of homelessness. 
Forty per cent of the cohort reported a history 
of state care of varied duration, moving 
between foster homes, residential care 
placements or residential placement homes. 
Their accounts of these experiences suggest 
that they did not integrate and, according 
to the authors, this instability produced 
exceptional vulnerability and deep resentment 
about their separation from parents and/or 
siblings. 
Negative peer association and problem 
behaviour were reported by some of the young 
people as contributing to poor relations with 
the family and caregivers. However, as the 
authors suggest, ‘[this] behaviour cannot be 
divorced from a range of other home based 
problems such as family illness, bereavement, 
conflict between parents or alcohol abuse by a 
parent’ (p. 16).
At the time of interview, only eight of the cohort 
did not use illicit drugs, with the average age of 
first drug use being 11.5 years for the males and 
13 years for the females. Fifty per cent of the 
cohort reported having used heroin, with almost 
all reporting their heroin use as problematic to the 
point of dependency. The majority of those who 
used heroin had first experimented with it after 
they became homeless. 
The vast majority of the young people in this 
research had used or were using the Out Of Hours 
Service (OHS) in the city centre. This crisis service 
was set up to respond to the accommodation and 
care needs of homeless youth aged 18 or under. 
Young people can only access the service by going 
to a Garda station after 8pm. It is then the duty of 
the gardai to contact the OHS social work team 
who will determine where to place the young 
person in the emergency service if returning to 
the home is not an option. This means that these 
young people continue to move between city-
centre hostels and become particularly vulnerable 
to exposure to alcohol and drug use, criminal 
activity and intimidation and bullying. According to 
the authors, ‘this initial period of contact with the 
city centre homeless “scene” was a common point 
of initiation into a whole range of risky behaviours 
n
n
n
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and, within a relatively short period of time, a large 
number had become immersed in the street-based 
social networks’ (p. 22). 
For example, when exposed to the experience of 
homelessness over an extended period, young 
people became heavily involved in using drugs 
and committing crime on a daily basis to finance 
their drug use. According to the authors, this led 
to a process of ‘acculturation’ into the street scene 
where they ‘learned the street competencies they 
need to survive by becoming embedded in social 
networks of homeless youths’ (p. 23). However, 
some of the cohort who managed to avoid the 
transient nature of hostel life and remained in the 
one place for an extended period of time were able 
to escape the street homeless scene, avoid drug use 
and attend school. 
This study provides a useful sociological insight 
into the lived experiences of young homeless 
people. The findings of this first phase, although 
in strict interpretative terms limited to this cohort, 
require attention from the various state agencies 
charged with preventing homelessness. Pillinger 
recommends this approach in the strategy on 
preventing homelessness.2 Supported measures 
need to be put in place at local level, particularly 
in the Dublin suburbs, to prevent young homeless 
people congregating in the city centre and 
becoming involved in drug use and criminal 
behaviour. The advantages of a decentralised 
approach to homelessness in Dublin is that these 
young people are accommodated closer to their 
homes, can continue contact with their families, 
and can remain in school. (Martin Keane)
1.   Mayock P and Vekic K (2006) Understanding 
youth homelessness in Dublin city: key findings 
from the first phase of a longitudinal cohort study. 
Dublin: Stationery Office.  
2.   Pillinger J (2006) Preventing homelessness: a 
comprehensive preventative strategy to prevent 
homelessness in Dublin, 2005–2010. Dublin: 
Homeless Agency.
Youth homelessness (continued)
Launch of Homeless Agency annual 
report 2005
The Minister of State at the Department of the 
Environment, Heritage and Local Government with 
responsibility for Housing and Urban Renewal, Mr 
Noel Ahern TD, launched the 2005 annual report of 
the Homeless Agency1 on 30 November 2006 at the 
agency’s headquarters in Parkgate Hall, Dublin 8. 
The report contains information on progress made 
on the strategic aims of the 2004–2006 action 
plan of the Homeless Agency, Making it home.2 The 
ultimate aim is to eliminate long-term homelessness 
and end the need for people to ‘sleep rough’ by 
2010. Examples of short-term progress outlined in 
the report include: 
a decrease of 19% in the number of households 
reporting as homeless recorded in Counted in 
20053
the allocation of local authority social housing 
to 183 homeless households, and housing 
association social housing to 89 homeless 
households (out of a total of 1,644 allocations of 
social housing in 2005)
the expansion of specialist healthcare services, 
including a pilot outreach service for people 
experiencing homelessness and alcohol issues in 
Ballymun
n
n
n
the development of the Dublin City Tenancy 
Sustainment Service as a measure to prevent 
homelessness
the completion of a large number of 
commissioned research and evaluation reports 
containing a range of recommendations that will 
be incorporated into the forthcoming Homeless 
Agency Partnership Action Plan 2007–2010. 
Commenting on the activities of 2005 in the report, 
the outgoing director, Dr Derval Howley, noted that 
it was a year that presented a mix of successes and 
challenges. Mr Cathal Morgan has taken over as the 
new director of the Homeless Agency. I wish him 
every success in his new position. (Martin Keane)
1.   Homeless Agency (2006) Annual report 2005: 
making it home. Dublin: Homeless Agency.
2.   Homeless Agency (2004) Making it home: An 
action plan on homelessness in Dublin 2004–2006. 
Dublin: Homeless Agency.
3.   Homeless Agency (2005) Counted in 2005. 
Dublin: Homeless Agency.
n
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The ultimate aim 
is to eliminate 
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and end the need 
for people to 
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In January 2007 the National Advisory Committee on 
Drugs (NACD) published its second progress report,1 
presenting its goals and achievements from August 
2003 to December 2005. The NACD advises the 
government in relation to the prevalence, prevention, 
treatment and consequences of problem drug use 
in Ireland, and it comes under the auspices of the 
Department of Community, Rural and Gaeltacht 
Affairs. In 2004, the government renewed the 
NACD’s mandate and a new work programme was 
developed to cover the years 2005–2008. 
The report comprises an overview of the NACD’s 
background and functions, its current work 
programme, publications, communication, ongoing 
research and research-funding allocation, and the 
findings of an external review. 
The NACD operates a broad-based committee 
system of experts drawn from relevant government 
departments, as well as from the statutory, 
community, voluntary, and academic agencies. Five 
sub–committees advise on the selection of research 
questions and the commissioning of research. The 
sub–committees cover the following aspects of drug 
use: consequences, early warning and emerging 
trends, prevalence, prevention and treatment/
rehabilitation.
In the period covered by the report, the NACD 
produced 19 publications as a result of commissioned 
or grant-aided research. The publications cover a 
range of drug-related subjects, including the first 
drug prevalence survey of Ireland and Northern 
Ireland, an overview of cocaine use in Ireland, drug 
use among the homeless and an examination of the 
role of family support services in drug prevention. 
The NACD’s ongoing commissioned external 
research programme is examining community 
studies, families’ experiences of support, drug 
prevalence, treatment outcomes, the national Drugs 
Awareness Campaign and the opiate prevalence 
study. Final reports from these projects are expected. 
The NACD’s internal research programme includes 
ongoing projects such as the Best Practice in 
Rehabilitation Briefing, the Drug Trend Monitoring 
System and interagency work for prevention. 
An external review conducted in 2004 by Talbot 
Associates concluded that the NACD is effective and 
meets a real need. (Louise Farragher)
The NACD Progress report is available on the NACD 
website at www.nacd.ie 
1.   National Advisory Committee on Drugs (2006) 
Progress report: August 2003–December 2005. 
Dublin: Stationery Office.
National Advisory Committee on Drugs 
– progress report
National Development Plan and the 
drugs issue
On 23 January 
2007 the National 
Development Plan 
2007–2013 (NDP) 
was launched.1 Setting 
out the government’s 
investment plans 
(€184 billion) for the 
next seven years, the 
NDP includes funding 
for measures to 
address the drugs issue 
under three of its five 
priority areas – Social Inclusion, Human Capital and 
Social Infrastructure. Some of this funding will support 
specifically drug-related measures, but larger amounts 
will support measures aimed at broader groups such 
as the socially excluded, the disadvantaged, the 
isolated, the vulnerable, those outside the mainstream 
educational system or ‘distant from the labour market’ 
– all categories in which drug misusers may be found.
Under the Social Inclusion Priority (€49.6 billion 
in total), the NDP earmarks €319 million for the 
‘National Drugs Strategy Sub-Programme’, subsumed 
under the Local and Community Programme. 
Allocated on an annual basis through the Vote of the 
Department of Community, Rural and Gaeltacht Affairs 
(which has responsibility for the overall co-ordination 
of the National Drugs Strategy), this €319 million will 
be channelled mainly through two existing funding 
mechanisms – the drugs task forces and the Young 
People’s Facilities and Services Fund (YPFSF). In respect 
of these two funding mechanisms, the NDP states:
n   The range of projects being undertaken 
through the Local Drugs and Regional 
Drugs Task Forces will be developed and 
strengthened over the coming years. Strategic 
plans, developed by the Drugs Task Forces 
and based on the identified needs of the 
areas involved, will continue to be central to 
the effort to counteract the problems of drug 
misuse.
In the period 
covered by the 
report, the 
NACD produced 
19 publications 
as a result of 
commissioned 
or grant-aided 
research. 
The NDP includes 
funding for 
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address the drugs 
issue under three 
of its five priority 
areas – Social 
Inclusion, Human 
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n   The YPFSF will continue to assist in the 
development of youth facilities (including 
sport and recreational facilities) and services in 
disadvantaged areas where a significant drug 
problem exists or has the potential to develop. 
The geographic coverage of the Fund may 
be expanded to other disadvantaged urban 
areas. The YPFSF will continue to target 10 to 
21 year olds who are ‘at risk’ due to factors 
including family circumstances, educational 
disadvantage or involvement in crime or 
substance misuse. The Fund will continue to 
build on and complement youth measures 
under the Children’s Programme in the areas 
where it is operational. (p. 265)
Over the past 10 years some €245 million has been 
allocated to these initiatives. Between 1997 and July 
2004, some €84 million was allocated to the local 
drugs task forces, and in 2006 some €12 million was 
allocated to the regional drugs task forces. Between 
2000 and 2006 the YPFSF was allocated €149.65 
million.
Acknowledging that the National Drugs Strategy 
will expire in 2008, the NDP endorses the current 
approach in the short-term – ‘the focus of drugs 
policy in the coming years will continue to be on 
illegal drugs that do the most harm and on the 
most vulnerable drug misusers, their families and 
communities’. It also highlights the partnership 
approach and the importance of evidence-based 
approaches. The NDP also confirms the pillars of 
the Strategy and the recommendations made in the 
mid-term review, including, among other things, 
extending the availability and range of treatment 
options in response to emerging needs, including 
the increased prevalence of cocaine and polydrug 
NDP and the drugs issue (continued)
Priority Programme Sub-Programme Comment
Human 
Capital  
(€25.8 
billion)
Training 
and Skills 
Development
Upskilling the 
Workforce  
(€2.8 billion)
Will seek to ensure that persons with little or no education or 
skills are not isolated and vulnerable to potential economic 
downturn. This will be delivered through measures which 
address early school leaving through combining education 
with labour market participation and upskilling.
Activation and 
Participation of 
Groups outside 
the Workforce 
(€4.9 billion)
Will provide training and development programmes for a 
wide range of groups requiring special interventions, such as 
Travellers and ex-offenders.
Social 
Infrastructure 
(€33.6 
billion)
 
Health 
Infrastructure 
Primary, 
Community and 
Continuing Care 
(€2.1 billion)
Will help to improve the physical facilities required to 
implement the national policy on team-based primary 
healthcare, including primary care infrastructure at local 
level, the delivery of local services in an integrated way, the 
fullest possible integration between hospital and community-
based services, better or increased access to services, and 
the development of strong community-based supports for 
vulnerable or targeted population groups. The NDP notes that 
access to a quality multi-disciplinary primary care service was 
one of the issues raised in public consultations on poverty and 
social inclusion, and that disadvantaged groups have greater 
needs for the varying elements of such a service and therefore 
potentially more to gain from it. 
Justice  
(€2.3 billion)
Not broken 
down into sub-
programmes
Detention and rehabilitation facilities are to be improved. 
New prison complexes in Dublin and Munster will enable the 
Irish Prison Service to develop modern rehabilitative facilities 
for prisoners. In respect of juvenile detention, investment will 
fund the redevelopment of existing detention facilities and the 
development of new facilities to meet the provisions of the 
Children Act 2001 in respect of offending children aged under 
18 years sentenced to detention by the courts.
Sports, 
Culture, 
Heritage and 
Community
Sports  
(€991 million)
Will support the availability of a range of facilities for sporting, 
exercise and recreational purposes. Among other benefits, 
sport is explicitly regarded as an alternative for young people 
at risk of engaging in anti-social activity, drug abuse or other 
criminal activity.
‘The focus of 
drugs policy in 
the coming years 
will continue to be 
on illegal drugs 
that do the most 
harm and on the 
most vulnerable 
drug misusers, 
their families and 
communities’.
Allocations under two other investment priorities, which may be expected to have an 
impact on drug-related matters
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Criminal justice drug policy  
in Ireland 
The Drug Policy Action Group (DPAG)1 is a member 
of the International Drug Policy Consortium, a 
global network of 24 national and international 
non-governmental organisations established 
‘to promote objective and open debate on the 
effectiveness, direction and content of drug 
policies’ and to support ‘evidence-based policies 
that are effective in reducing drug-related harm’.2 
The first policy paper published by the DPAG 
examines current criminal justice drug policy in 
Ireland.3 The paper was written by two leading 
commentators on the drugs issue in Ireland, Seán 
Cassin OFM, founder of Merchants Quay Ireland 
and a member of the National Drugs Strategy 
Team, and Dr Paul O’Mahony, Trinity College 
lecturer and author of a number of books on the 
Irish criminal justice system.
An analysis of criminal justice policy must consider 
not only the way in which drug laws are formed 
in statute but also how they are implemented 
in practice throughout the system, from police 
to courts. Highlighting the separation of powers 
between the legislature and the judiciary, the 
authors illustrate this point by suggesting that 
‘sentencing practice by judges tends to be more 
lenient than the laws envisage with only a small 
proportion of all convictions for all drug related 
offences resulting in a prison sentence’ (p. 3).
The causative complexity of the drugs–crime 
relationship is not, the authors suggest, sufficiently 
reflected in policy formation. For example, the 
report criticises ‘most politicians’ and An Garda 
Siochána for adhering to policy statements that 
‘explicitly minimise distinctions between drugs 
and forms of use’ (p. 3). Present policies in Ireland, 
they argue, ‘make no distinction between harms 
resulting from different kinds of drug use and no 
distinction between the actions of different user 
groups’. According to the authors, a consequence 
of this perceived failure to distinguish between 
the harmful effects of different drugs is that it can 
encourage misperceptions among experimental 
drug users and lead them into further more 
harmful drug use. It is argued, for example, that 
people who occasionally use cannabis and ecstasy 
with little ill effect ‘can be led by the prevalent 
exaggerated claims about the dangers of the less 
dangerous drugs to dismiss as equally harmless 
the more problematic drugs like heroin or crack 
cocaine’ (p. 4).
The central argument of the report is that there is 
an excessive reliance on legislation and the criminal 
justice system as a mechanism for dealing with 
the country’s illegal drug problems and that this is 
generating more problems than it is solving. This 
apparent imbalance is reflected in disproportionate 
expenditure on drug services by the Department of 
Justice, Equality and Law Reform, when compared 
with expenditure by the Department of Health and 
Children. Furthermore, the authors argue that most 
of the recently introduced criminal drug laws target 
‘already disadvantaged drug using groups’ rather 
than drug suppliers. They suggest that, given that 
most drug-related prosecutions are for possession 
rather than supply, 
it is the user who is predominantly targeted 
and more deeply inserted into a criminal 
justice system that can do little to promote 
personal development or the removal of 
obstacles to personal growth. This over 
reliance on the criminal system merely serves 
to recycle successive generations through 
criminal processes that become a life norm 
that perpetrates [sic] the criminal and 
disadvantaged sector. (p. 4)
Drug Policy Action Group: Policy Paper 1
Priority Programme Sub-Programme Comment
Human 
Capital  
(€25.8 
billion)
Training 
and Skills 
Development
Upskilling the 
Workforce  
(€2.8 billion)
Will seek to ensure that persons with little or no education or 
skills are not isolated and vulnerable to potential economic 
downturn. This will be delivered through measures which 
address early school leaving through combining education 
with labour market participation and upskilling.
Activation and 
Participation of 
Groups outside 
the Workforce 
(€4.9 billion)
Will provide training and development programmes for a 
wide range of groups requiring special interventions, such as 
Travellers and ex-offenders.
Social 
Infrastructure 
(€33.6 
billion)
 
Health 
Infrastructure 
Primary, 
Community and 
Continuing Care 
(€2.1 billion)
Will help to improve the physical facilities required to 
implement the national policy on team-based primary 
healthcare, including primary care infrastructure at local 
level, the delivery of local services in an integrated way, the 
fullest possible integration between hospital and community-
based services, better or increased access to services, and 
the development of strong community-based supports for 
vulnerable or targeted population groups. The NDP notes that 
access to a quality multi-disciplinary primary care service was 
one of the issues raised in public consultations on poverty and 
social inclusion, and that disadvantaged groups have greater 
needs for the varying elements of such a service and therefore 
potentially more to gain from it. 
Justice  
(€2.3 billion)
Not broken 
down into sub-
programmes
Detention and rehabilitation facilities are to be improved. 
New prison complexes in Dublin and Munster will enable the 
Irish Prison Service to develop modern rehabilitative facilities 
for prisoners. In respect of juvenile detention, investment will 
fund the redevelopment of existing detention facilities and the 
development of new facilities to meet the provisions of the 
Children Act 2001 in respect of offending children aged under 
18 years sentenced to detention by the courts.
Sports, 
Culture, 
Heritage and 
Community
Sports  
(€991 million)
Will support the availability of a range of facilities for sporting, 
exercise and recreational purposes. Among other benefits, 
sport is explicitly regarded as an alternative for young people 
at risk of engaging in anti-social activity, drug abuse or other 
criminal activity.
NDP and the drugs issue (continued)
use; implementing the (soon to be announced) 
integrated rehabilitation framework as a priority in the 
coming years; and using education and awareness 
programmes and sport and recreational alternatives to 
divert people (particularly young people) away from 
drug use.
The drugs issue will also be addressed through other 
programmes under the Social Inclusion Priority, 
including those targeting children and young people, 
people of working age who find themselves outside 
the mainstream educational system, at a distance 
from the labour market, or in need of reintegration 
into society after spending time in prison, and 
communities seeking to identify and address issues 
and challenges, such as the drugs issue, in their own 
areas. (Brigid Pike)
1.   National Development Plan 2007–2013: 
Transforming Ireland – a better quality of life for all. 
Dublin: Stationery Office. Available on line at  
www.ndp.ie Funding under the NDP is allocated 
across five investment ‘priorities’, and under each 
of these priorities there is a series of ‘programmes’ 
(28 in total) and ‘sub-programmes’ (some 86 in 
total).
The causative 
complexity of 
the drugs–crime 
relationship 
is not, the 
authors suggest, 
sufficiently 
reflected in policy 
formation.
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Accepting that supply control initiatives can offer 
‘a containment of criminal elements’, the authors 
argue that an over-reliance on this approach 
promotes public attitudes that are both anti-drug 
and anti-drug-user. They suggest that, at times 
of ‘moral panic’, and fuelled by an often alarmist 
media approach, public and political attitudes 
towards drug users can harden, thus creating and 
perpetuating ‘a culture of marginalised people’ who 
are also criminalised.
The primary focus of drug policy, according to the 
authors, should be on addressing the demand for 
drugs and the reasons why some people engage 
in problem drug use. They advocate a humanistic 
approach to tackling such problems, premised on 
the belief that ‘people are capable and willing to 
develop themselves when the internal and external 
obstacles to that development are removed or 
reduced’ (p. 5). Calling for what they regard as a 
more appropriate balance between supply control 
and demand reduction initiatives, the authors 
highlight ‘ambiguities’ or apparent conflicts 
in policy approaches. For example, anti-social 
behaviour measures such as evictions obtained 
under the Housing (Miscellaneous Provisions) Act 
1997 can render drug users homeless, thereby 
contributing to increased levels of ‘drug use, 
nuisance and health risks’ (p. 5). Another example 
they cite is what they see as the ‘persistent disparity 
in approaches between the Health Services and the 
Prison Services whereby equal access to services 
ceases for those beginning a custodial sentence’. 
The report calls for a greater use of ‘pragmatic’ 
approaches to problematic drug use, such as 
methadone prescription and needle exchange.
Despite the centrality of the multi-agency and 
partnership approach to the National Drugs 
Strategy 2001–2008, the authors question whether 
there is ‘adequate understanding or commitment’ 
to the partnership approach at senior levels in the 
departments of Justice, Health and Finance. In 
support of this position, the authors identify what 
they see as ‘the failure to mainstream pilot projects 
and provide them with a statutory framework, 
the lack of projected plans to cover the ongoing 
developments in service delivery, and [the] failure 
to apply benchmarking to NGOs’ (p. 5). They state 
that the perceived failure at departmental level has 
ramifications throughout the whole infrastructure of 
the National Drugs Strategy. 
This apparent lack of partnership working 
at government department level leads to 
considerable frustration in the system at 
local, regional and national team levels and 
especially amongst those who are exceptionally 
committed to the partnership approaches.  
(p. 5)
Finally, the authors call upon the National Drugs 
Strategy Team (NDST) ‘to assume its hitherto 
dormant role of initiating and developing policy for 
the Government’ (p. 6). 
The DPAG makes a number of specific 
recommendations, including:
The Cabinet sub committee on social inclusion 
should request the Law Reform Commission to 
assist them to review and propose repeals or 
revisions of drug laws.
The NDST should appoint a dedicated policy 
sub-group to review changes in Ireland’s 
criminal justice drug policy.
Ireland should adopt a system of classification 
of drug substances similar to that in Britain, 
where drugs are grouped on the basis of their 
harmfulness to the individual and to society.
The role of public representatives on local and 
regional drugs task forces should be focused on 
implementing better drug laws which make a 
distinction between drug activities that actually 
cause harm and those with low or no harmful 
consequences.
The Health Service Executive should support 
greater access to harm reduction facilities like 
needle exchanges, safe injection rooms and 
more widely available alternative prescribing 
options for long-term drug users.
An Garda Síochána should develop more 
focused programmes of training in harm 
reduction approaches for Garda recruits. 
Despite some academic contributions 
and a discussion of the merits of cannabis 
decriminalisation at the National Crime Forum,4 
Irish debate in the area of criminal justice drug 
policy has been limited. The DPAG report is an 
important contribution in that respect. (Johnny 
Connolly)
1.  www.drugpolicy.ie
2.  www.idpc.info
3.   Cassin S and O’Mahony P (2006) Criminal justice 
drug policy in Ireland. Policy Paper 1. Dublin: 
Drug Policy Action Group.
4.   National Crime Forum (1998) National Crime 
Forum: report 1998. Dublin: Stationery Office.
n
n
n
n
n
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On 2–4 November 2006 the European Forum for Urban 
Safety, a network of more than 300 European local 
authorities, hosted an international conference entitled 
‘Safety, Democracy and Cities’. The conference was seeking to 
develop a European model of security. Among the workshops 
held in the course of the conference was one on drugs. 
The conference adopted a policy document, the Zaragoza 
Manifesto. zaragoza2006.fesu.org  
On 6–7 November 2006 the European Parliament hosted 
a gathering of local, regional and national authorities, as 
well as civil society organisations from Europe and beyond, 
who presented on existing and future alternatives in 
European drug policy, and explored the role of Europe in 
the process towards the UN summit in 2008.The conference 
was organised by ENCOD, European Coalition for Just and 
Effective Drug Policies. www.encod.org 
On 15 November 2006 Coolmine Therapeutic Community 
launched its strategic plan A pioneering record: A dynamic 
future 2006–2008. Committed to drug-free or abstinence-
based outcomes for its clients, Coolmine acknowledges 
that over the past 30-odd years drug treatment policy in 
Ireland ‘has shifted gradually towards a “harm-reduction” 
philosophy’. In his foreword, the Chairperson writes, ‘We 
now have a greater consciousness of our unique and vital role 
as colleagues to providers who use different approaches to 
tackling the same issues. Emerging best practice models and 
environmental changes mean that a one-size-fits-all approach 
is not appropriate or effective for Ireland today.’   
www.coolminetc.ie 
On 22 November 2006 the Special Residential Services 
Board (SRSB) hosted its annual ‘network event’. The purpose 
of the network events is to explore areas of best practice and 
discuss topical issues that are related to young people within 
the child care and educational systems in Ireland today. The 
theme of this year’s event was ‘Working with Young People 
Who Will Not Engage’. www.srsb.ie 
In November 2006 the Children’s Research Centre 
published a research study, Free time and leisure needs of 
young people living in disadvantaged communities, by Tina 
Byrne, Elizabeth Nixon, Paula Mayock and Jean Whyte. 
It is a study into the free time and leisure needs of young 
people (aged 12 to 18 years) living in four areas in Ireland 
designated as disadvantaged under the Government’s 
RAPID Programme. Among the findings of the research, in 
respect of social environment, the researchers reported that, 
‘While describing a strong attachment to their communities, 
the young people were very aware of their negative 
characteristics, including high levels of exposure to the use 
and sale of drugs. There was unanimous agreement among 
the young people that there are insufficient public and 
private leisure amenities available to them in their areas.’  
www.tcd.ie/childrensresearchcentre
On 7 December 2006, under the auspices of the British–Irish 
Council (BIC), a Ministerial Meeting on the Misuse of Drugs 
was held in Belfast. Chaired by Noel Ahern TD, Minister of 
State with responsibility for the National Drugs Strategy, the 
meeting focused on the challenges presented by cocaine use.  
Ministers found that similar issues arose in relation to cocaine 
in each administration but that the problem was at various 
stages of development in the different jurisdictions.  
www.british-irishcouncil.org 
On 7 December 2006 the Drug Treatment Centre Board 
(DTCB) held its inaugural conference on adolescent 
addiction, Treatment of adolescent addiction – A national 
problem. The aim of the conference was to equip professionals 
working with adolescent substance misusers with knowledge 
and skills that will assist in the delivery of appropriate services. 
www.addictionireland.ie
On 14 December 2006 the Blood Borne Virus Forum 
(BBVF) made a presentation to the Oireachtas Joint 
Committee on Health and Children. A voluntary group 
established in Ireland in 2001 and comprising representatives 
of statutory, voluntary and community agencies, the BBVF 
called for ‘equivalence of care for all people affected by 
hepatitis C no matter how they picked it up’ and called 
on the Oireachtas Committee ‘to consider calling for a 
comprehensive national policy so that we can examine 
service development for everybody. We would appreciate 
if an appropriate budget were allocated to support service 
development. We seek the release of the regional hepatitis C 
strategy, which is under review again, and we would like it to 
be made national.’ www.oireachtas.ie 
In December 2006 Eurobarometer 66: Public opinion in the 
European Union – First results was published. Fieldwork was 
conducted in September–October 2006. More than a quarter 
(26%) of EU citizens surveyed agreed, and two-thirds (68%) 
disagreed, with the statement: ‘Personal consumption of 
cannabis should be legalised throughout Europe’. Young 
Europeans tended to be opposed to the legalisation of 
cannabis (57% of respondents aged 15 to 24 disagreed with 
the statement). However, opinions varied from country to 
country. In Finland (8%) and Sweden (9%) the idea was 
rejected outright, whereas in the Netherlands just under half 
of the respondents felt that cannabis should be legalised 
throughout Europe (49%). In Ireland the rate of agreement 
was above the EU average (30%).  
www.ec.europa.eu/public_opinion  
On 12 January 2007 the National Advisory Committee on 
Drugs (NACD) published its Progress report: August 2003–
December 2005. It also released a series of research summary 
sheets covering the same period. www.nacd.ie 
In January 2007 the Garda policing plan 2007 was launched. 
The plan includes actions and performance targets in respect 
of drug trafficking, dealing and using; enforcing the law in 
relation to underage drinking and substance abuse in both 
public places and licensed premises; and increasing the 
number of detections for both drink and drug driving.  
www.garda.ie 
(Compiled by Brigid Pike)
In brief

drugnet 
IRelAND

The Council of Europe’s response to drug use and 
drug trafficking is carried out through a multi-
disciplinary co-operation group known as the 
Pompidou Group. Named after French president, 
Georges Pompidou, it was set up in 1971 and now 
comprises 35 member states.
The mission of the Pompidou Group is to contribute 
to the quality of European drug policies, practices 
and research by identifying issues raised through 
practical experience, promoting evidence-based 
policies and facilitating communication between 
professionals of various disciplines and between EU 
and non-EU countries. The work of the Pompidou 
Pompidou Group work  
programme 2007–2010
Objectives Activities/topics Expected output
Objective 1: Demand reduction
Prevention
Promote participation by young 
people in prevention
European prevention prize Three prizes every other year 
for projects exemplifying 
participatory approaches
Promote internet-based support Programme on virtual training 
and resource centre
Interactive support tool for 
practitioners working with 
parents
Treatment
Identify needs, problems and 
experience-based knowledge
Consider treatment modalities for 
specific substances and groups
Identify good practice approaches
Objective 2: Supply control 
Criminal justice
Review the operation of drug 
courts/ specialised magistrates
Assess implementation 
procedures and evaluation
Identify good practice
Review judicial co-operation and 
the process of joint investigations
Identify barriers in practice Identify good practice standards 
and future priorities
Airports
Improve law enforcement in 
European airports
Facilitate access to databases for 
frontline officers 
Identification of data needs
Objective 3: Transversal issues
Ethics and human rights
Explore ethical issues and human 
rights basis for drug policies and 
programmes
Implications of workplace drug 
screening  
Implications of research findings 
in neurosciences and genetics
Promotion of good practice
Research
Register research activity Develop web-based research 
registry in collaboration with 
EMCDDA
Inventory/Register
Co-operation
Promote inter-service  
co-operation at  
implementation level 
Develop European network of 
partnerships at frontline level 
responding to drug problems
Exchange of best practice; 
training; strategies to address 
public nuisance
Promote drug awareness among 
media personnel
Develop European training 
project for journalists on drug 
prevention and use
Training courses; national  
follow-up activties; examples  
of new reporting formats
Since mid-January 2007 the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) 
has taken on a more active role in monitoring new 
drug-use patterns and emerging trends throughout 
the 27 member states.
The European Parliament and the Council of the 
EU have adopted a new mission statement for the 
EMCDDA, replacing the one founding the agency 
in 1993. While reaffirming the EMCDDA’s main 
purpose as providing EU member states with ‘factual, 
objective, reliable and comparable information at 
European level concerning drugs and drug addiction 
and their consequences’, the new document 
broadens the scope of the EMCDDA’s tasks. 
The EMCDDA is now allowed to collect, register 
and analyse information on ‘emerging trends in 
polydrug use’ — the simultaneous use of more than 
one drug — including the combined use of licit and 
illicit psychoactive substances. 
Reference is also made in the new mission statement 
to providing information on best practice in the EU 
member states and facilitating exchange of such 
practice between them. This will include the sharing 
of experience in areas such as drug prevention, 
and reducing supply and drug-related harm. The 
EMCDDA will also develop tools and instruments to 
help member states and the European Commission 
monitor and evaluate national and EU drug policies 
respectively.
Another key aspect of the new remit is closer co-
operation with the law enforcement body, Europol, 
to attain maximum efficiency in monitoring the 
drugs problem. Among other things, the two bodies 
will continue to work together in monitoring new 
psychoactive substances appearing on the European 
illicit drug market.
The EMCDDA may also be called on to transfer its 
know-how to certain non-EU countries, such as 
official candidates for EU accession and countries in 
the Western Balkans. This is likely to entail creating 
and reinforcing links with the European Information 
Network on Drugs and Drug Addiction (Reitox) 
and assisting in the building and strengthening of 
national drug observatories (national focal points).
For further information, visit www.emcdda.europa.eu 
Group is structured around six platforms: 
prevention, treatment, criminal justice, airports, 
ethics and human rights, and research.
In November 2006, the Ministerial Conference, 
which is the political authority of the Pompidou 
Group and which meets every four years, agreed a 
draft work programme for 2007–2010.1 The work 
programme concentrates on the following main 
objectives: developing effective programmes in 
the areas of demand reduction and supply control, 
addressing transversal issues and facilitating co-
operation and joint activities. Some of the planned 
activities to be undertaken in line with these 
objectives are outlined in the table below.
The expected results from the activities undertaken 
through the work programme include the 
identification of barriers in practice and priorities for 
further action, and the setting of standards of good 
practice. The format in which these outcomes are 
presented and disseminated varies and is tailored 
to the needs of specific target groups, be they 
policy makers, practitioners or researchers. Outputs 
may include policy papers, recommendations and 
guidelines for standards, comparative studies, 
expert reports or on-line resources. A particular 
focus is placed on education and training and 
the transfer of know-how. Another priority of the 
Pompidou Group is to identify overlaps and avoid 
duplication in practice, particularly among the 
various international organisations active in the 
drugs area. Consequently, co-operation initiatives 
are planned with a range of groups, including 
the Mediterranean Network (Algeria, Morocco, 
Tunisia, France and the Netherlands), the European 
Monitoring Centre for Drugs and Drug Addiction 
and the World Health Organization. The work of 
the Pompidou Group is evaluated on an ongoing 
basis. (Johnny Connolly)
1.   Pompidou Group Ministerial Conference (2006) 
Work Programme 2007–2010. Strasbourg: 
Council of Europe. Available on the Council of 
Europe website at www.coe.int/pompidou
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EMCDDA broadens its scope 
A particular  
focus is placed  
on education  
and training and 
the transfer of  
know-how. 
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The inclusion of licit substances in European drug 
policies is discussed in the EMCDDA annual report 
selected issues 2006.1 This report analyses the current 
approach advocated by EU countries to their drugs 
strategies, the rationale behind extending the scope 
of drugs strategies and the potential repercussions an 
extended drugs strategy would have on drugs services 
and responsible bodies at operational level. 
The EU Drugs Strategy 2005–2012 adopted in 
2004 is directed at illicit drug use, although it does 
acknowledge the health-related and social problems 
caused by the use of illicit drugs in combination with 
legal psychoactive substances such as alcohol, tobacco 
and medicines. However, there is an increasing body 
of opinion which believes that the scope of drugs 
strategies should be broadened to encompass licit 
addictive substances such as alcohol, tobacco and 
medicines, as well as illicit drugs.  
Of the 27 countries surveyed for this report, 24 
reported the existence of a national drugs strategy 
but just eight countries reported that their strategies 
included both drugs and alcohol (Table 1). The basis 
for the inclusion of both substances within a single 
strategy differs across countries. In some countries the 
justification comes from a public health perspective 
which considers the distinction between licit and illicit 
substances to be irrelevant – licit substances can cause 
addiction and consequently pose a major health and 
social problem. It is difficult to differentiate between 
users of licit and illicit substances due to the increasing 
prevalence of polydrug use. Another reason for 
broadening national strategies is based upon a medico-
scientific consensus that takes into account the causes 
and consequences of addictive behaviours, regardless 
of the legality of the substance. This approach places 
greater emphasis on common behaviours than on 
substances. 
Ireland is identified as one of 11 countries with a 
drugs strategy that addresses only illicit drugs but 
which includes links to licit substances in the context 
of prevention and treatment. While the Irish National 
Drugs Strategy Building on experience: National Drugs 
Strategy 2001–2008 refers mainly to illicit drugs there 
are links between it and the national alcohol policy 
in terms of prevention approach. These links aim 
‘to ensure complementarity between the different 
measures being taken’2 in the field of prevention. 
The possibility of developing a combined alcohol and 
drugs strategy in Ireland is being examined. One of the 
recommendations of the steering group responsible 
for overseeing the mid-term review of the National 
Drugs Strategy was that ‘a working group involving 
key stakeholders of both the alcohol and drugs areas 
should be established to explore the potential for better 
co-ordination between the two areas and how synergies 
could be improved. The working group should also 
examine and make recommendations on whether a 
combined strategy is the appropriate way forward’.3
The field of prevention is the area where  
extending the remit of national drugs policies is most 
often apparent. In practice, prevention programmes 
address licit and illicit substances together. Prevention 
of drug use is associated with prevention of 
addictive behaviours which involve both licit and 
illicit substances. The main objective of prevention 
programmes is to delay or prevent the introduction 
into the use of legal drugs as it is now recognised that 
the early use of licit substances is the most important 
risk factor for progression to illicit drug use. This is 
particularly evident among programmes targeting 
young people which focus first on alcohol and tobacco 
as the longer that initiation to tobacco and alcohol can 
be delayed, the greater the reduction in later substance 
abuse problems. 
In most countries, the extension of treatment 
programmes to include both licit and illicit substances 
is due to the increasing prevalence of polydrug use. 
Polydrug use presents challenges to drug monitoring 
systems that traditionally have focused on the use of 
individual substances. In Ireland there are no official 
European drug policies – extending 
beyond illicit drugs?
Table 1   Substances or behaviours targeted in national drugs strategies
Illicit drugs Alcohol Tobacco Medicines Other substances or addictions
Belgium + + + + +
Czech Republic + + +   
Germany + + + + +
Spain + + + +  
France + + + + +
Cyprus + + + +  
Romania + + + +  
Norway + +  +  
Sources: Reitox national focal points
In practice, 
prevention 
programmes 
address licit 
and illicit 
substances 
together.
It is 
difficult to 
differentiate 
between 
users of licit 
and illicit 
substances 
due to the 
increasing 
prevalence of 
polydrug use.
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links between alcohol and drug treatment services, 
but in practice many drug services also treat clients 
with problem alcohol use. The reason for this is that 
one-fifth of those treated for problem alcohol use 
also misuse drugs. The trend towards integrating 
treatment centres or establishing joint treatment 
centres for licit and illicit substances is particularly 
common in countries which have extended their 
drugs strategies to include licit substances.
While the majority of countries have established 
drugs strategies, the scope of these can vary 
greatly. However, a number of trends appear to be 
developing which seem to support the integration 
of licit and illicit substances in some respects. 
These mainly include prevention programmes and, 
increasingly, treatment programmes which are now 
taking into account both licit and illicit substances.  
(Deirdre Mongan)
1.   EMCDDA (2006) Annual report 2006: selected 
issues. Luxembourg: Office for Official 
Publications of the European Communities.
2.   Department of Community Rural and Gaeltacht 
Affairs (2001) Building on experience: National 
Drugs Strategy 2001–2008. Dublin: Department 
of Community, Rural and Gaeltacht Affairs.
3.   Steering group for the mid-term review of the 
National Drugs Strategy (2005) Mid-term review 
of the National Drugs Strategy 2001–2008. 
Dublin: Department of Community, Rural and 
Gaeltacht Affairs.
European drug policies (continued)
EU research funding and the drugs issue
Launched in December 2006, the 7th Framework 
Programme for Research and Technological 
Development (FP7) is the EU’s main instrument for 
funding research in Europe. It will run from 2007 to 
2013. 
In February the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA) published 
information on FP7 relevant to drug researchers 
under two main headings – Health, and Socio-
Economic Sciences and Humanities.
For the full EMCDDA analysis of FP7, visit www.
emcdda.europa.eu. For more information about 
FP7 as a whole, visit http://cordis.europa.eu/fp7/
home_en.html
New Directory of training courses for 2007
The National Documentation Centre on Drug Use 
has published a new edition of the Directory of 
courses and training programmes on drug misuse 
in Ireland. Thirty-six providers sent us information 
about 100 courses for this second edition – a 45% 
increase in submissions from last year. We would 
like to thank all of those who made contributions.
The Directory lists a range of training available, 
from single sessions to courses lasting up to two 
years. A wide variety of training standards, methods 
and approaches are represented. Some courses do 
not refer directly to drugs or addiction but aim to 
develop broad skills, such as supervision, facilitation 
and counselling techniques, which may be of 
interest to those working in this area. 
Most courses are targeted at a specific audience. In 
particular, a large number of courses and training 
programmes have been designed for workers in 
the area of drug misuse and for parents. Many are 
offered at both in-house and external locations. 
This year there is just one course specifically for 
young people. 
Perhaps the most significant feature of this edition 
is the increased opportunities for those who wish 
to study aspects of drug misuse or addiction at 
certificate, diploma and degree level. We do not 
assess the quality of courses listed; we present 
information as supplied by the course co-ordinators 
on course length, assessment, qualifications and 
accreditation. 
Most course providers are based in Dublin (64%), 
although counties outside Dublin are better 
represented than in the first edition. There are 
course providers in Wexford, Waterford, Tipperary, 
Cork, Kildare, Meath, Offaly, Cavan, Donegal 
and Mayo. Although many cater specifically for 
people in their locality, some also offer courses on a 
regional or national basis. 
We make every effort to include all relevant courses 
in the Directory but, inevitably, some agencies 
providing courses and training in drug misuse were 
overlooked, while others were unable to respond in 
time. We hope, therefore, to update this directory 
annually. (Mary Dunne)
Course co-ordinators who wish to revise an 
existing entry or include a new course in the 
next edition of the Directory may request an 
application form from mdunne@hrb.ie
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Changes at the HRB
Change in HRB management structure 
The Health Research Board (HRB) has changed its 
management structure from a two-layer one (the chief 
executive and eight divisions) to a three-layer one (the chief 
executive, three directorates and eight units). The change in 
structure came into effect on 1 January 2007, following an 
organisational review. The directorate layer was introduced 
to combine units (formerly ‘divisions’) with similar or 
linked functions into three groups (directorates) in order to 
enhance the effectiveness and efficiency of these functions 
throughout the organisation. 
Change of name and increase in role
The Drug Misuse Research Division considered this an 
opportune time to change its name to the Alcohol and 
Drug Research Unit (ADRU), to reflect the expansion of 
its work activities to include alcohol-related research. This 
change came into effect on 1 January 2007. The ADRU is 
one of four units in the Health Information and In-House 
Research Directorate.
The ADRU is a multi-disciplinary team of researchers and 
information specialists who provide objective, reliable and 
comparable information on the drug and alcohol situation, its 
consequences and responses in Ireland. The ADRU maintains 
two national drug-related surveillance systems and is the 
national focal point for the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA). The Unit also 
manages the National Documentation Centre on Drug Use. 
The ADRU disseminates research findings, information and 
news in Occasional Papers, in the Overview series, and in this 
quarterly newsletter, Drugnet Ireland. Through its activities, 
the ADRU aims to inform policy and practice in relation to 
drug and alcohol use. 
Contact details for the unit are: 
Alcohol and Drug Research Unit 
Third Floor, Knockmaun House 
42–47 Lower Mount Street 
Dublin 2 
t  +353 1 676 1176  
f  +353 1 6618567 
e  adru@hrb.ie
Recent publications
Books
How to read a paper: the 
basics of evidence-based 
medicine (3rd edition)
Greenhalgh T 
Blackwell Publishing 2006,  
229 pp. 
ISBN -13: 978 1 4051 3976 2
This book is intended for anyone, 
whether medically qualified or 
not, who wishes to find their way 
into the medical literature, assess 
the scientific validity and practical 
relevance of the articles they find 
and, where appropriate, put the results into practice. These 
skills constitute the basics of evidence-based medicine. 
This is what the author said in 1996 in the preface to the 
first edition of this book, which has since become a standard 
reader in many medical nursing schools, much reprinted and 
translated into eight languages. This third edition maintains 
the clarity and directness – and humour – of the original 
in its ‘no frills’ introduction to evidence-based medicine 
(EBM). Many of the chapters in this edition are essentially 
unchanged, apart from adding illustrations and updating the 
reference lists. Some chapters – notably those on searching, 
qualitative research, systematic review and implementing 
evidence-based practice – have been fundamentally revised  
 
because the fields have moved on significantly since the 
previous edition. 
The chapter titles reflect the book’s unpretentious approach. 
The first five chapters are: Why read papers at all?; 
Searching the literature; What is this paper about?; Assessing 
methodological quality; and Statistics for non-statisticians. 
The author makes the point that it is only when the questions 
raised in these early chapters have been addressed that one 
should proceed to the next stage in the EBM process – critical 
appraisal. Chapters 6–12 describe how to critically appraise 
papers that report drug trials, diagnostic or screening tests or 
questionnaire research, those that summarise other papers 
(systematic reviews), that tell you what to do (guidelines), 
that tell you what things cost (economic analyses), and those 
that go beyond numbers (qualitative research). 
The final chapter, Getting evidence into practice, questions 
why health professionals are slow to adopt evidence-
based practice and discusses how their behaviour might 
be influenced. It attempts to identify what an evidence-
based organisation looks like, and what interventions exist 
for achieving organisational change. An appendix has 13 
checklists, each linked to a chapter, for finding, appraising 
and implementing evidence. There is a second, one-page 
appendix giving a formula for calculating the effects of an 
intervention.
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Young people and drugs:  
care and treatment
Council of Europe Pompidou 
Group 2006, 252 pp.
The Pompidou Group’s Working 
Group on Treatment focused 
on the treatment of young 
drug users (aged up to 25 
years) and adopted a series 
of recommendations and 
orientations to improve practice 
in this domain. As a result, this 
book, containing contributions 
from some 15 members of the Group, was published in 
November 2006. It is intended for people who deal directly 
with young people with problematic drug use, such as 
physicians (GPs), psychologists, pedagogues, addiction-care 
specialists and teachers. 
The publication contains the following chapters, each with its 
own references, which comprise an independent whole but 
can be read separately: 
Definitions of dependency and recreational, regular, 
problematic, harmful drug use
Epidemiological basis
Risk and protective factors in adolescent and youth drug 
use
How to establish contact with young people who use 
drugs
Screening and assessment
Treatment and treatment planning
Co-morbidity of substance abuse: diagnosis and 
treatment implications in adolescents
Treatment considerations for pregnant drug users
The first of two final chapters draws conclusions and 
recommendations from the eight chapters above, while the 
last chapter summarises the main points made in the book.
Drug abuse handbook  
(2nd edition)
Karch S (ed.) 
CRC Press 2007, 1267 pp. 
ISBN-13: 13 978 0 8493 1690 6
This handbook is a 
comprehensive guide to 
the pharmacology and 
pharmacokinetics of abused 
drugs, and offers an extensive 
overview of the pathology of 
drug abuse. The first edition 
was published in 1998. Acknowledging the advances in 
knowledge about drug abuse in the past decade, largely in 
the fields of molecular biology and neurochemistry, the editor 
argues that progress in understanding its effects has been 
slow in the field of pathology and in other medical specialities. 
n
n
n
n
n
n
n
n
Most of the book is concerned with forensic science, the 
clinical management of toxic patients and the management 
of addicted patients, with authoritative contributions from 
experts in the legal, medical and treatment fields. The editor 
believes that at some point there must be a convergence of 
these fields, bringing all of these different disciplines together 
to form an evidence-based field.  
The book examines criminalistics, pathology, neurochemistry, 
alcohol, drug testing, treatment, medical complications, drug-
related death investigation, and the ethical, legal and practical 
issues involved. New material in this edition includes:
advances in DNA research on forensic investigation
the genetics behind sudden cardiac death and other 
‘invisible’ diseases
drug-testing methods, protocol, practicality and 
applications in the workplace and in criminal justice 
systems
the neurochemistry of drugs of abuse, including 
nicotine
the effects of blood doping and the future of genetic 
performance enhancement.
Each of the fourteen chapters opens with a detailed contents 
list and ends with a bibliographic reference list. Appendices 
include a glossary of terms in forensic toxicology, a list of 
common abbreviations, references for methods of drug 
quantitative analysis and sample calculations. The book has a 
43-page index.
Homelessness directory 
2007/2008: the directory of 
hostels, supported housing and 
other services in Dublin
Homeless Agency 2006, 100 pp.
This is the fourth edition of 
the directory of services for 
people who are experiencing 
homelessness in Dublin. The 
Homeless Agency produced 
and published the directory in 
conjunction with the Resource Information Service, a London-
based charity. This edition includes a comprehensive listing of 
all specialist homeless services – for adults, families and young 
people – and includes information on support available from 
mainstream and general services. It provides details on access 
criteria and referral procedures, and information on rights and 
entitlements. 
The directory is divided into three main sections. The first 
section has maps of Dublin city and surrounding council 
areas, and provides general information about the kinds 
of services available, how they are currently organised and 
delivered, and their statutory responsibilities. The second 
section contains alphabetical lists of hostels and housing 
projects in four subsections: emergency hostels, domestic 
violence, transitional housing and long-term supported 
housing. Each entry contains information on the service, 
the target group, the facilities provided and public transport 
n
n
n
n
n
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access. Location maps are included in the case of emergency 
hostels. The third section covers advice and support services, 
with subsections listing food and day centres providing 
practical support, housing advice agencies, street services, 
health and mental health, alcohol and drugs, education 
and training, and counselling services, among others. The 
directory has five indexes, allowing the reader to find out-
of-hours services, young peoples’ projects and women’s 
projects, and to search for services alphabetically or by local 
authority area.
Journal articles
The following abstracts are from recently published articles 
relating to the drugs situation in Ireland.
Alcohol problems, marriage, and treatment: developing a 
theoretical timeline
Loughran H 
Journal of Social Work Practice in the Addictions 2006; 6(1–
2):31–48
While research findings over the past twenty years have 
consistently supported the efficacy of couples work with 
people experiencing alcohol related problems, in the field of 
practice in Ireland there is little evidence of the development 
of interventions based on a couples/marital perspective. 
This paper examines the place of marital work in the alcohol 
field through a review of the literature from the 1950s to 
the present in order to discover the limitations in theory and 
research that might explain the reluctance of practitioners to 
adopt this method of intervention. 
Violence and aggression in the Drug Treatment Centre 
Board
Whitty P and O’Connor JJ 
Irish Journal of Psychological Medicine 2006; 23(3): 89–91
In this study, the authors sought to determine the prevalence 
of and the factors associated with violent and aggressive 
incidents among clients attending an out-patient methadone 
stabilisation and detoxification programme in Dublin.   
Incident reports from a two-year period were retrospectively 
examined. The authors also obtained information on 
demographics, main drug of abuse, timing and location of 
the incident as well as psychiatric and physical co-morbidity 
among the perpetrators from case note review.
A total of 295 incidents occurred over the study period. The 
overall rate of violence and aggression was 85 per 1,000 
clients attending the centre per year. Most incidents involved 
verbal abuse. Females were significantly more likely than 
males to be involved in assaults. A high proportion of clients 
(80%) who were physically aggressive tested positive for 
benzodiazepine medication. The authors concluded that 
levels of recorded violence have remained stable but that 
racial abuse has increased in recent years. The relatively 
low overall rate of violence suggests that existing measures 
have helped reduce the number of aggressive and violent 
incidents in the centre. Most of the victims were doctors, 
nursing staff or general assistants. This finding reflected their 
respective roles in the centre, which included limit setting 
and dealing with positive drug screens among clients.
Zopiclone misuse: an update from Dublin
Bannan N, Rooney S and O’Connor J 
Drug and Alcohol Review 2007; 26(1): 83 –85
The prevalence of zopiclone misuse in clients attending 
a methadone maintenance programme in Dublin 
through detection of its degradation product, 2-amino-5-
chloropyridine (ACP) on urinalysis is outlined. Urine samples 
from all 158 clients were tested for the presence of ACP, 
opiates, benzodiazepines, cocaine, alcohol and cannabis. Of 
the 37 (23%) clients who tested positive for ACP, 23 (62%) 
were interviewed. A profile of zopiclone misusers is outlined, 
including details of demographics, drug history, viral status, 
recent urinalysis results and opinions on zopiclone. Of the 
14 (38%) clients who were not interviewed, information 
was obtained from their clinical casenotes and documented 
urinalysis results. The prevalence of zopiclone misuse was 
reported as 23%. Benzodiazepines were the most popular 
drug of misuse, with zopiclone followed by heroin/opiates. 
Zopiclone is being misused by drug users in Dublin in the 
context of many other drugs. Prescribing of zopiclone should 
be restricted, especially among drug misusers.
Introducing safer injecting facilities (SIFs) in the Republic 
of Ireland: ‘chipping away’ at policy change
O’Shea M 
Drugs: education, prevention and policy 2007; 14(1):75–88
Safer injecting facilities (SIFs) have been introduced in many 
countries throughout Europe over a number of years, and 
more recently have been established in Canada and Australia. 
This study conducted in Dublin sought to examine the 
policy implications of introducing safer injecting facilities in 
Ireland as a logical development of harm-reduction policy. 
A triangulation method of data collection was adopted that 
comprised semi-structured interviews with 16 drug users and 
structured interviews with key personnel and policy makers in 
the drug field. The study revealed that the majority of drug 
users were injecting in public places, had a surprising level of 
knowledge of SIFs, and indicated a willingness to use such 
facilities. The findings of the study also revealed very mixed 
feelings among policy makers and key personnel and showed 
that, among those in favour of such an innovation, there was 
a preference for doing so with the maximum of discretion. 
The study concludes that it is perhaps ‘a bridge too far’ in the 
current political climate.
The cost of drug use in adolescence: young people, 
money and substance abuse
McCrystal P, Percy A and Higgins K 
Drugs: education, prevention and policy  
2007; 14(1): 19–28
It is now common for young people in full-time compulsory 
education to hold part-time jobs. However, while the 1990s 
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experienced a rise in illicit drug use particularly among young 
people and an increase in the level of interest in identifying 
factors associated with drug use, little attention has been 
paid to the influence of the money young people have to 
spend and its potential links with drug use. In this study, 
4,524 young people living in Northern Ireland completed 
a questionnaire in school year 10 (aged 13/14 years). The 
findings suggested that there was a positive association 
between the amount of money young people received (and 
its source) and higher rates of drug use. The study concludes 
that money, and how it is spent by young people, may be 
important factors for consideration when investigating drug 
use during adolescence. The findings may help inform drug 
prevention strategies, particularly through advice on money 
management, and taking responsibility for their own money.
(Compiled by Louise Farragher and Joan Moore)
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Upcoming events 
(Compiled by Louise Farragher – lfarragher@hrb.ie)
March
26–28 March 2007 
Drugs, Alcohol and Criminal Justice –  
the shape of things to come 
Venue: University of Warwick 
Organised by / Contact: Michelle Vatin, 
The Conference Consortium 
Email: michelle@conferenceconsortium.org  
www.conferenceconsortium.org
This conference is an opportunity for 
those working in the closely related fields 
of drugs, alcohol and criminal justice to 
discuss and debate major challenges facing 
services and service users. Participants will 
hear and learn about current models of 
good practice, linked with sessions aimed at 
influencing the shape of policy and practice 
in the future. Sessions include:
Motivating the coerced – what do we 
mean by motivation?
All I want is a room somewhere 
– the role of housing and residential 
rehabilitation in addressing drug and 
alcohol use/misuse
What’s happening in the world of 
alcohol?
April
17 –25 April 2007 
Cork Drug Awareness Week 2007 
Organised by / Contact: Aoife Ní 
Chonchúir or Mella Magee   
Community Outreach Drug Awareness 
Project, Cork City Partnership, Sunbeam 
Industrial Estate, Millfield, Mallow Road, Cork 
Tel: +353 (021) 4302310 
Email: anichonchuir@partnershipcork.ie  or 
mmagee@partnershipcork.ie 
Cork Drug Awareness Week aims to raise 
awareness and signpost information so that 
communities, families and professionals 
know where to go for assistance and 
information on drug and alcohol services. 
Each day of the week targets groups / areas 
affected by substance use.
n
n
n
Tuesday, 17 April 2007 
’Families, Friends and Addiction‘  
Time: 7:30pm – 9:30pm 
Venue: Jury’s Hotel, Western Rd. Cork
Thursday, 19 April 2007  
Conference: ’Addiction – Treatment and 
the 4 Tier Model’ 
Time: 9:30am – 2:00pm 
Venue: Clarion Hotel, Lapp’s Quay, Cork
24–25 April 2007 
Information Day 
Time: 9:30am – 2:00pm on both days 
Venue: to be confirmed
Information: Various stands and groups will 
present on the day, providing a broad range 
of information on drug and alcohol services 
in Cork. The target audience includes 
school-going students, young people, 
teachers, parents etc. The day will be 
informative and enjoyable and will include 
light entertainment, i.e. competitions, 
music, drama, DVD, refreshments and 
presentations by several well-known Cork 
personalities! 
19–20 April 2007 
Management of Drug Users in  
Primary Care 
Venue: Hilton Birmingham Metropole Hotel 
Organised by / Contact: The Royal  
College of General Practitioners, and 
Healthcare Events 
www.healthcare-events.co.uk 
Information: The conference is the 
largest event in the UK for GPs, shared 
care workers, drug users, nurses and 
other primary care staff, specialists, 
commissioners, and researchers interested 
and involved in the management of 
drug users in primary care. This year’s 
conference aims to address that ‘whole 
systems approach’, and how healthcare 
professionals can all work more effectively 
together to provide the best care for 
patients who use drugs and/or alcohol.
May
1 May 2007 
Drugs and Alcohol Today London 
Venue: Business Design Centre, London 
Organised by / Contact:  
Tel: +44 (0)870 890 1080 
Email: exhibitions@pavpub.com 
www.drugsandalcoholtodayexhibition.com 
Information:  This one-day event, 
comprising a full and comprehensive 
seminar programme and a large exhibition, 
will provide a unique opportunity for 
professionals and managers involved in 
preventing and treating substance misuse, 
service users and those interested in joining 
the profession to come together to debate 
the big issues, share best practice and 
network.
9–11 May 2007 
Unhooked Thinking 2007 –  
Love and Baggage 
Venue: The Guildhall, Bath 
Organised by / Contact: Unhooked 
Thinking 
www.unhookedthinking.com 
Information: Unhooked Thinking is an 
unusual, international and multi-disciplinary 
conference enquiring into the nature 
of addiction. This year the relationship 
between love and addiction is explored. 
Each of the three days has a theme: 
Relationships: 9 May 
Love and Conflict: 10 May 
Family: 11 May 
n
n
n
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17–19 May 2007 
Making Time for Treatment: 4th 
UK/European Symposium on Addictive 
Disorders 
Venue: Millennium Gloucester Hotel, 
London, Kensington 
Organised by / Contact: UK/European 
Symposium on Addictive 
www.ukesad.org
Information:  Learn practical techniques 
and cutting-edge knowledge from leading 
world experts – over 60 presenters sharing 
knowledge in over 36 presentations.  
Presentations and workshops will address 
one or more of the three core themes 
below, with both national and international 
contributions.
therapeutic effectiveness and family-of-
origin issues
brief interventions
policies and interventions to treat 
offenders
June
6–9 June 2007 
11th EFTC European Conference on 
Rehabilitation and Drug Policy 
Venue: Hotel Domina Grand Media, 
Ljubljana, Slovenia 
Organised by / Contact: European 
Federation of Therapeutic Communities, 
Conference Secretariat: Cankarjev dom, 
Cultural and Congress Centre, Mateja Peric, 
Pre_ernova 10, SI-1000 Ljubljana , Slovenia. 
Tel: +386 1 241 71 39 
www.eftc-europe.com/conferentie 
Information: The EFTC and the drug 
rehabilitation programmes of Slovenia are 
delighted to invite you to this conference in 
the lovely and historic city of Ljubljana. The 
overall theme for the conference is ’Working 
Together – Partners for Change’ and there 
are four sub-themes:
working with the criminal justice system
not just addictions
families and communities
contributors to change.
The focus of the conference will be the role 
and experience of therapeutic communities 
within the context of overall responses to 
dependency.
n
n
n
n
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August
26–31 August 2007    
T’2007 
Venue: Seattle USA 
Organised by / Contact:  International 
Council on Alcohol Drugs and Traffic Safety 
(ICADTS) and The International Association 
of Forensic Toxicologists (TIAFT) 
Tel: +001 (206) 262–6000 
www.t2007.org  
Information: The first joint meeting of 
ICADTS and TIAFT will also feature the 
8th Ignition Interlock Symposium. This 
conference will cover traditional topics of 
each organisation’s meetings but will also 
provide opportunities for cross-fertilisation 
of ideas, and networking within and 
between the organisations.
September
20 September 2007  
28th Annual EAP Conference: Drugs and 
Alcohol at Work – Complying with the 
Safety, Health and Welfare at Work Act 
2005
Venue: Carlton Hotel, Dublin Airport, 
Ireland 
Organised by / Contact: EAP Institute / 
Anita Furlong, EAP Institute, 143 Barrack 
Street, Waterford, Ireland  
Tel: + 353 (51) 855733  
Fax:  +353(51) 879626  
Email: anita@eapinstitute.com 
Cost: €425.00 (includes conference dinner)
Information: The Safety, Health and Welfare 
at Work Act 2005 obliges employers to 
remove employees from their place of work 
who are under the influence of intoxicants 
(defined as drugs and alcohol).  A finding by 
the Labour Court in 2006 that alcoholism is 
a disability will oblige employers to provide 
treatment and rehabilitation to employees.  
This one-day conference will address the 
following issues:
Managing drugs and alcohol at work
Trade union approach
Legal risk management
Maintaining a drug-free work place
Employee drug testing 
Managers training
n
n
n
n
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Upcoming events (continued)
Improving health through research and information
Drugnet Ireland mailing list
If you wish to have your name 
included on the mailing list for 
future issues of Drugnet Ireland, 
please send your contact details 
to:
Alcohol and Drug Research Unit  
Health Research Board 
Knockmaun House  
42–47 Lower Mount Street  
Dublin 2  
Tel: 01 676 1176 ext 127 
Email: adru@hrb.ie
Please indicate whether you 
would also like to be included  
on the mailing list for  
Drugnet Europe.
The Alcohol and Drug Unit 
(ADRU) of the Health Research 
Board is a multi-disciplinary team 
of researchers and information 
specialists who provide objective, 
reliable and comparable 
information on the drug 
situation, its consequences and 
responses in Ireland. The ADRU 
maintains two national drug-
related surveillance systems and 
is the national focal point for the 
European Monitoring Centre for 
Drugs and Drug Addiction. The 
unit also manages the National 
Documentation Centre on Drug 
Use. The ADRU disseminates 
research findings, information 
and news through its quarterly 
newsletter, Drugnet Ireland, and 
other publications. Through 
its activities, the ADRU aims to 
inform policy and practice in 
relation to drug use.
